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Abstract
Background The cellular mechanisms underlying the age-associated loss of muscle mass and function (sarcopenia) are poorly
understood, hampering the development of effective treatment strategies. Here, we performed a detailed characterization of
age-related pathophysiological changes in the mouse neuromuscular system.
Methods Young, adult,middle-aged, andold (1,4,14, and 24–30months old, respectively) C57BL/6Jmicewere used.Motor be-
havioural and electrophysiological tests andhistological and immunocytochemical procedureswere carried out to simultaneously
analyse structural, molecular, and functional age-related changes in distinct cellular components of the neuromuscular system.
Results Ageing was not accompanied by a significant loss of spinal motoneurons (MNs), although a proportion (~15%) of them
in old mice exhibited an abnormally dark appearance. Dark MNs were also observed in adult (~9%) and young (~4%) animals,
suggesting that during ageing, some MNs undergo early deleterious changes, which may not lead to MN death. Old MNs were
depleted of cholinergic and glutamatergic inputs (~40% and ~45%, respectively, P < 0.01), suggestive of age-associated alter-
ations in MN excitability. Prominent microgliosis and astrogliosis [~93% (P < 0.001) and ~100% (P < 0.0001) increase vs. adults,
respectively] were found in old spinal cords, with increased density of pro-inflammatory M1microglia and A1 astroglia (25-fold
and 4-fold increase, respectively, P < 0.0001). Ageing resulted in significant reductions in the nerve conduction velocity and the
compound muscle action potential amplitude (~30%, P < 0.05, vs. adults) in old distal plantar muscles. Compared with adult
muscles, old muscles exhibited significantly higher numbers of both denervated and polyinnervated neuromuscular junctions,
changes in fibre type composition, higher proportion of fibres showing central nuclei and lipofuscin aggregates, depletion of
satellite cells, and augmented expression of different molecules related to development, plasticity, and maintenance of neuro-
muscular junctions, including calcitonin gene-related peptide, growth associated protein 43, agrin, fibroblast growth factor
binding protein 1, and transforming growth factor-β1. Overall, these alterations occurred at varying degrees in all the muscles
analysed, with no correlation between the age-related changes observed andmyofiber type composition or muscle topography.
Conclusions Our data provide a global view of age-associated neuromuscular changes in a mouse model of ageing and help
to advance understanding of contributing pathways leading to development of sarcopenia.
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Introduction
The rise of human life expectancy is a contributing factor of
frailty, a common clinical syndrome in the elderly, which is
characterized by a state of increased vulnerability to adverse
outcomes with subsequent disability and morbidity. Frailty is
considered a consequence of a collective age-related decline
in the function and reserve of multiple organs, with particular
involvement of the neuromuscular, endocrine, and immuno-
logical systems.1,2 Sarcopenia, defined as the progressive loss
of muscle mass, strength, and function, is a key component
of physical frailty. Sarcopenia leads to mobility impairments
and falls in older adults, negatively affecting their quality of
life.3 The prevalence of sarcopenia in people over age 60 years
has been reported to be 8–40% depending on the sarcopenia
definition used; starting about the age 50, humans lose 1–2%
of muscle mass per year, with an annual decline in muscle
strength of 1.5% between ages 50 and 60 and of 3% thereaf-
ter.4,5 Sarcopenia in the elderly has been proposed to have a
multifactorial aetiology, which includes chronic inflammation
(‘inflammageing’), metabolic and endocrine alterations, poor
nutrition, mitochondrial dysfunction, oxidative damage, and
neurogenic factors.6–8 Although notable progress has been
made in the understanding of causative factors leading to age-
ing sarcopenia, the exact cellular and molecular mechanisms
responsible for this process still remain elusive. Moreover,
there is a remarkable divergence in reported results on the
age-related changes observed in distinct components of the
neuromuscular system and their contribution to progressive
muscle wasting in the elderly. These differences are particu-
larly noticeable when comparing data from different ageing
animal models and, even more, when compared with neuro-
muscular changes reported in human studies. These differ-
ences could be due to the fact that many studies focus on
specific components of the neuromuscular system rather than
a more holistic analysis of the neuromuscular system in its
entirety.
Some studies have provided information indicating that an
impaired neuromuscular innervation could account for the
loss of muscle mass in advanced ages9; in line with this, struc-
tural changes in both the presynaptic and postsynaptic por-
tions of the neuromuscular junction (NMJ) have been
reported to occur with age in both animals and humans.10–
12 Other studies in aged rodents have reported morphological
alterations in motor nerve terminals with increased extent
and complexity of their arborization, accompanied by frag-
mentation of postsynaptic endplates. All these changes ap-
pear to reflect continuous cycles of muscle denervation and
reinnervation with ageing.13 Overall, this process of NMJ re-
modelling is considered to be a consequence of motoneuron
(MN) degeneration with age. Some investigations in humans
have reported a significant decrease in the number of MNs
in people over 60 years.14 Similarly, loss of MNs with advanc-
ing age has been reported in rodents as well.9,15–17 This MN
death could account for the age-associated loss of motor
units, particularly of those innervating fast-twitch muscles,
and the decrease in muscle power.8,18–20 However, the as-
sumption that MN degeneration is the cause of age-related
alterations in NMJs is controversial. Thus, some studies per-
formed in murine models have not reported a significant loss
of MNs with age.21,22 Whatever the case, the fact that
age-related alterations in motor nerve terminals are a conse-
quence of an intrinsic skeletal muscle pathology rather than a
primary defect in MNs cannot be excluded. In fact, it is well
known that muscle fibres play an important role in the main-
tenance of NMJs.23–27 Therefore, a retrograde process (‘dy-
ing-back’) leading to progressive NMJ disruption and MN
dysfunction could result from a defect inherent to muscle fi-
bres with the subsequent decline in muscle-derived trophic
signals necessary to maintain the integrity and stability of
the neuromuscular presynaptic components. This theory is,
in part, strengthened by findings indicating that NMJs in
humans are remarkably stable throughout the entire adult
lifespan,28 suggesting that the structural and functional neu-
romuscular alterations occurring in the elderly have their
main cause in intrinsic muscle deficiencies.
To elucidate the mechanisms leading to age-associated
neuromuscular alterations, we undertook a detailed charac-
terization of the pathophysiological changes occurring in the
mouse neuromuscular system over the course of ageing.
Here, we examined, as a whole, the various distinct cellular
components, which shape the neuromuscular system and
are essential for proper motor function. We simultaneously
analysed structural and molecular changes occurring with
age in spinal cord MNs and glia, dorsal root ganglion (DRG)
sensory neurons, motor nerves, NMJs, and skeletal muscles
of C57BL/6JRj mice. To assess whether age-related changes
in muscles are influenced by their regional location (distal
or proximal) and specific function, different hindlimb muscles
with a distinct position and myofiber type composition were
studied. Moreover, to examine in vivo the potential
age-related changes in muscle innervation, an electrophysio-
logical analysis using quantitative electromyography was per-
formed. A better understanding of the neuromuscular
changes occurring with ageing and the pathogenic mecha-
nisms leading to sarcopenia is crucial towards development
of effective interventions aimed at prevention and treatment.
Materials and methods
Animals
All animal handling and experimentation procedures were
conducted in accordance with the ethical standards laid down
in the 1964 Declaration of Helsinki and its later amendments,
the European Communities Council Directive 2010/63/EU for
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the care and use of laboratory animals, and the norms
established by the Generalitat de Catalunya [published in
the Diari Oficial de la Generalitat de Catalunya (DOGC)
2073, 1995]. All experiments were previously evaluated and
approved by the Committee for Animal Care and Use of the
Universitat de Lleida and the Committee for Ethics on Exper-
imental Animal and Human Research of the Universitat
Autònoma de Barcelona. All efforts were made to minimize
suffering and reduce the number of animals in agreement
with the European Communities Council Directive (24 No-
vember 1986; 86/609/EEC).
C57BL/6JRj mice were supplied by Janvier Labs (Saint
Berthevin, France) and were included in four groups of age
(young, adult, middle-aged, and old) according to previously
defined criteria.29 Briefly, young age was considered at 1–
2 months, adult age at 4–10 months, middle age at 10–
18months, and old age at ~19months and older. The animals
used in the present study had the following ages: 1 month
(young), 4 months (adult), 14 months (middle-aged), and
24–30 months (old). To avoid potential bias due to gender,
only male animals were used in this study. Mice were housed
(3 per cage) in the animal care facility of the Universitat de
Lleida on a 12-h light/dark cycle, having ad libitum access to
standard laboratory chow and water. According to previous
defined criteria,30,31 mice displaying tumours, physical abnor-
malities, and/or evidence of disease were excluded from the
study and euthanized by an overdose of pentobarbital
(30 mg, intraperitoneally).
Motor behaviour tests
To evaluate the impact of age progression on motor skills,
mice were periodically weighed and carefully examined.
Open-field (for assessing locomotor activity) and rotarod
and grip strength (for assessing motor coordination and bal-
ance) tests were subsequently performed every 4 weeks ac-
cording to previously described guidelines.32 All tests were
conducted by the same investigator. Except for open-field
test, every mouse was evaluated 3 times with a 15min recov-
ery period between them; the value obtained in the best test
performance was used as the final score. Open-field test was
performed by the automated recording of mouse movements
using Smart Video Tracking software (v2.5.21, Panlab Harvard
Apparatus, Holliston, MA, USA); different parameters such as
time, distance, entries in zones, and average speed were
measured.
Electrophysiology tests
Nerve conduction tests were performed in adult and old
mice. For motor nerve conduction tests, the sciatic nerve
was stimulated percutaneously by means of single pulses of
25 μs duration delivered through a pair of needle electrodes
placed at the sciatic notch. The compound muscle action po-
tential (CMAP, M wave) and the H-reflex wave were recorded
from tibialis anterior (TA) and plantar interossei (PL) muscles
with microneedle electrodes.33 The H/M ratio was calculated
as the quotient of the maximal H wave and maximal M wave
amplitude for each recorded muscle. For sensory nerve con-
duction tests, the recording electrodes are placed near the
digital nerves of the fourth toe to record the compound sen-
sory nerve action potential following stimulation of the sciatic
nerve as mentioned previously. All potentials were amplified
and displayed on a digital oscilloscope (Tektronix 450S,
Tektronix, Beaverton, OR, USA) at appropriate settings to
measure the amplitude from baseline to the maximal nega-
tive peak and the latency from stimulus to the maximal neg-
ative peak. To ensure reproducibility, the recording needles
were placed under microscope to secure the same placement
on all animals guided by anatomical landmarks. During the
tests, the mice body temperature was maintained constant
between 34°C and 36°C by means of a thermostat heating
pad.
We also performed a motor unit number estimation
(MUNE) test in the TA muscle, using the same setting as for
the motor nerve conduction test. The protocol used was
based on the incremental technique.34 Starting from sub-
threshold intensity, the sciatic nerve was stimulated with sin-
gle pulses of gradually increased intensity until the first CMAP
response appeared, representing the first motor unit re-
cruited. With the next stimuli, quantal increases in the re-
sponse were recorded. Increments >50 μV were considered
as the recruitment of an additional motor unit. The amplitude
of a single motor unit was calculated as the mean of more
than 15 consistent increases. The estimated number of motor
units resulted from the equation: MUNE = CMAP maximal
amplitude/mean amplitude of single motor unit action
potentials.
Tissue sample preparation, histological analysis,
and motoneuron counts
At chosen time points, mice were anaesthetized and
transcardially perfused with 4% paraformaldehyde (PFA) in
0.1 M phosphate buffer (PB), pH 7.4. After animal perfusion,
spinal cords, L4 DRGs and ventral nerve roots (VRs), and en-
tire hindlimb skeletal muscles were rapidly dissected. Nerve
roots were then immersed in 1% PFA and 1% glutaraldehyde
in 0.1 M PB at pH 7.4 for 24 h. Muscle samples were proc-
essed for histology and further morphometry according to
previously described procedures.35 Muscles examined include
the extensor digitorum longus (EDL), a fast-twitch muscle in-
volved in the dorsiflexion of the foot and extension of toes
during locomotion; the TA, a fast-twitch muscle, which helps
with dorsiflexion and inversion of the foot; the soleus (Sol), a
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relative slow-twitch muscle in mice, which plays an important
function in maintaining the standing posture and is also uti-
lized for plantarflexion during walking; and the gracilis (Gra),
a fast-twitch, more proximal muscle, located in the medial
side of the thigh, which is mainly involved in adduction of
the limb and also assists knee flexion.36
For histology and MN counts, the spinal cords surrounded
by their vertebrae were maintained in Bouin’s solution for
2 months and embedded in paraffin. Serial transverse sec-
tions (14 μm thick), obtained throughout the entire lumbar
(L1–L5) segment, were stained with haematoxylin and eosin
(H&E). α-MNs, located in the ventral horn, were identified
by their size (soma diameter > 20 μm), morphology (multipo-
lar appearance, prominent nucleolus, and abundant Nissl
granules in cytoplasm), and topography in Lamina IX of grey
matter. MNs were counted blindly on one side of every
10th section, according to previously described criteria.37,38
Briefly, only MNs with a large nucleus and a visible clump of
nuclear material and a substantial intense basophilic cyto-
plasm were included in the counts. These stringent criteria
make not necessary the use of a correction factor for double
counting.37 The number of cells counted was multiplied by 10
to obtain the total number of MNs per ventral horn.
Ventral nerve roots were postfixed in 1% osmium tetroxide
and embedded in Embed 812 (Electron Microscopy Sciences,
Fort Washington, PA, USA) epoxy resin, following standard
procedures. Semithin transversal sections (1 μm thick) were
stained with methylene blue and imaged using an Olympus
60x/1.4NA PlanApo oil immersion objective (Olympus) and a
DMX 1200 Nikon (Tokyo, Japan) digital camera.
Muscles were cleaned, cleared of the excess of connective
tissue, blotted dry, and weighed. After this, muscles were
postfixed in 4% PFA in 0.1 M PB (pH 7.4), cryoprotected with
30% sucrose in 0.1 M PB, embedded in tissue freezing me-
dium (Triangle Biomedical Sciences, Durham, NC, USA), and
frozen. Cryostat transverse sections (16 μm thick), obtained
from the mid-belly of the muscle, were stained with H&E.
Immunocytochemistry and imaging
For immunocytochemical analysis, lumbar spinal cords, L4
DRGs, and skeletal muscles were postfixed by immersion in
4% PFA in 0.1M PB (pH 7.4), either overnight (for spinal cords
and DRGs) or for 2 h (for muscles), and cryoprotected. Tissue
samples were embedded in tissue freezing medium and fro-
zen. Longitudinal (16 μm thick for muscles) and transverse
(16 μm thick for muscles and 14 μm thick for spinal cords
and DRGs) serial cryostat sections were obtained and stored
at 80°C.
Tissue sections were sequentially rinsed in
phosphate-buffered saline containing 0.1% Triton X-100 for
30 min, blocked in normal goat serum or normal horse se-
rum, and subsequently incubated with the chosen primary
antibody. The primary antibodies used are indicated in Table
1.
After incubation with the primary antibody, sections were
washed with phosphate-buffered saline and incubated for 1 h
at room temperature with the appropriate secondary fluores-
cent antibodies labelled with one of the following fluoro-
chromes (1:500): Alexa Fluor 488, Alexa Fluor 546
(Molecular Probes, Eugene, OR, USA), Cy3, or Cy5 (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA). The
spinal cord sections were finally counterstained with blue
fluorescent NeuroTrace Nissl staining (1:100; Molecular
Probes). Muscle sections were incubated with Alexa Fluor
555-conjugated α-bungarotoxin (α-Bgtx, 1:500; Molecular
Probes) to identify postsynaptic acetylcholine receptors.
Some sections were also stained with 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI, 50 ng/mL; Molecular
Probes) for DNA staining. To avoid lipofuscin-like autofluores-
cence, slides with sections of spinal cord from old mice were
treated with the Autofluorescence Eliminator Reagent
(Merck, Madrid, Spain), following incubation with the second-
ary antibodies. Some slides with DRG were stained with fluo-
rescein isothiocyanate (FITC)-conjugated Bandeiraea
simplicifolia lectin [isolectin B4 (IB4), 1:25; Sigma-Aldrich, St.
Louis, MO, USA].
After washing, slides were coverslipped using an
anti-fading medium containing 0.1 M Tris–HCl buffer
(pH 8.5), 20% glycerol, 10% Mowiol, and 0.1% 1,4-
diazabicyclo[2,2,2]octane. Slides were examined with and
Olympus BX51 epifluorescence microscope (Olympus, Ham-
burg, Germany) equipped with a DP30BW camera or
FluoView 500 or FluoView 1000 Olympus laser scanning con-
focal microscopes. For comparisons, slides from different an-
imals and experimental conditions were processed in parallel
for immunocytochemistry and subsequent imaging. The same
scanning parameters were used for the acquisition of images
corresponding to different experimental groups. For spinal
cord immunocytochemical studies, digital images of the en-
tire lumbar region were obtained from every 30th section.
Electron microscopy
Ultrathin sections of L4 VRs embedded in Embed812 were
obtained and counterstained with uranyl acetate and lead cit-
rate. Sections were observed in a JEOL JEM 1400 (JEOL, To-
kyo, Japan) transmission electron microscope.
Image analysis and morphometry
Image and morphometric examinations were performed on
blinded images by two independent investigators. Digital im-
ages were analysed with ImageJ software (US National Insti-
tutes of Health, Bethesda, MD, USA).
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Myofiber cells counts and size measurements were per-
formed in a single random image per muscle taken from its
mid-belly and immunostained for laminin. Myofiber type com-
position of different muscles was examined in transversal sec-
tions immunostained with different isoform-specific anti-
myosin heavy chain (I, IIA, and IIB) antibodies (for types 1,
2A, and 2B myofibers, respectively). Images were captured
with a digital camera (Olympus DP30BW), and the number of
types 1 (slow-twitch), 2A (fast-twitch fatigue-resistant), and
2B (fast-twitch fast-fatigable) myofibers was counted and
expressed as a percentage of total myofiber number. The pro-
portion of myofibers showing central nuclei was also counted
on images from DAPI-stained sections. The percentage of
myofibers showing lipofuscin aggregates and the number and
the area of these aggregates were alsomeasured using ImageJ.
The cytoarchitecture of the NMJs was assessed in longitudi-
nal immunostained sections of muscles. Z-stack optical sec-
tions (1 μm thick) were obtained with the confocal
microscope and projected to reconstruct NMJs; maximum in-
tensity projections of stacks were created using the micro-
scope software. Three to five sections were examined for
each muscle, in which NMJs from different randomly selected
visual fields were analysed. NMJ size was measured by deter-
mining the area of manually outlined α-Bgtx-labelled
postsynaptic site. Full or partial denervation is considered
when the postsynaptic site was not completely apposed by
the nerve terminal immunostained for both neurofilament
68 KDa (NF) and synaptic vesicle protein 2, as presynaptic
marker. Single or polyinnervation was estimated counting
the number of preterminal axons, stained with anti-NF anti-
body, entering a single postsynaptic site: an NMJ was defined
as polyinnervated when it was occupied by two or more
axons. Terminal sprouting was quantified by counting the
number of NF-stained axonal processes coming from a nerve
terminal that escaped from an α-Bgtx-labelled postsynaptic
site; the number of sprouts per NMJ counted was referred
as a percentage of the total number of NMJs examined per
muscle. On the basis of the morphological appearance of the
postsynaptic site, the degree of NMJ maturity was classified
as plaque, folds, perforations, or pretzel-like (secondary)
structure ranging from immature to mature, according to pre-
viously described criteria.39 An NMJ was defined as
fragmented when its postsynaptic site displayed a
discontinued appearance, with five or more acetylcholine re-
ceptor (AChR) islands stained with α-Bgtx and/or unusually
small and irregular clusters of AChR. Immunostaining for calci-
tonin gene-related peptide (CGRP), growth associated protein
43 (GAP-43), agrin, fibroblast growth factor binding protein 1
Table 1 Primary antibodies used for immunocytochemistry
Target Host species Source/catalogue no. Dilution
14-3-3 Mouse monoclonal BD Transduction Laboratories (San Jose, CA)/F46820 1:100
Agrin Mouse monoclonal Millipore (Temecula, CA)/MAB5204 1:100
Calcitonin gene-related peptide Rabbit polyclonal Sigma-Aldrich (St. Louis, MO)/C8198 1:1000
CD206 Goat polyclonal R&D Systems (Minneapolis, MN)/AF2535 1:100
Choline acetyltransferase Goat polyclonal Millipore/AB144 1:250
Fibroblast growth factor
binding protein 1
Rabbit polyclonal Bioss Antibodies,
(Boston, MA)/bs-1768R
1:80
Glial fibrillary acidic protein Chicken polyclonal Abcam (Cambridge, UK)/ab4674 1:1000
Growth associated
protein 43 (H-100)










Goat polyclonal Abcam/ab5076 1:500
Laminin Rabbit polyclonal Abcam/ab30320 1:1000
Mac-2 Rat monoclonal Cedarlane (Burlington, Canada)/CL8942AP 1:800
Matrix metalloproteinase-9 Goat polyclonal Sigma-Aldrich/M9570 1:10
Myosin heavy chain I Mouse monoclonal Developmental Studies Hybridoma Bank
[DSHB] (Iowa City, IA, USA)/A4-840
1:5
Myosin heavy chain IIA Mouse monoclonal DSHB/SC-71 1:20
Myosin heavy chain IIB Mouse monoclonal DSHB/BF-F3 1:20
Neurofilament 68 KDa Chicken polyclonal Abcam/ab72997 1:1000
Paired box protein 7 Mouse monoclonal R&D Systems/MAB1675 1:50
Parvalbumin Mouse monoclonal Swant (Marly, Switzerland)/PV235 1:2000
S100β Rabbit polyclonal Abcam/ab41548 1:3000
Synaptic vesicle protein 2 Mouse monoclonal DSHB/SV2 1:1000
Transforming growth factor-β1 Rabbit polyclonal Abcam/ab92486 1:100
Vesicular acetylcholine transporter Guinea pig polyclonal Synaptic Systems
(Gottingen, Germany)/#139105
1:500
Vesicular GABA transporter Guinea pig polyclonal Synaptic Systems/#131004 1:200
Vesicular glutamate transporter 1 Rabbit polyclonal Synaptic Systems/#135302 1:1000
Vesicular glutamate transporter 2 Guinea pig polyclonal Synaptic Systems/#135404 1:200
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(FGFBP1), and transforming growth factor-β1 (TGF-β1) was es-
timated based on pixel intensity after background subtraction
in NMJs, which postsynaptic site was visualized with α-Bgtx;
an average of 50 NMJs per muscle was examined to assess
the different morphometric parameters and the intensity of
immunostaining. Any NMJ that was difficult to examine due
to its location and/or orientation was excluded from the anal-
ysis. AChR extrasynaptic accumulations were quantified by es-
timating the number of α-Bgtx labelled spots in muscle
sections after synaptic α-Bgtx exclusion; an average of 35mus-
cle sections from 3–5 animals per condition were analysed.
The analysis of central synapses, CGRP and matrix
metalloproteinase-9 (MMP-9) in MNs, and glia in the ventral
horn was performed on confocal images taken from every
30th section of the entire lumbar spinal cord. The number
and area of vesicular acetylcholine transporter (VAChT), ve-
sicular glutamate transporter 1 (VGluT1), VGluT 2, and vesic-
ular GABA transporter (VGAT)-immunoreactive synaptic
boutons on MN somata were counted and measured by de-
lineating their periphery on the screen; only boutons that
were in close contact with MNs displaying a large nucleus
and visible nucleolus were included in the counts, and num-
bers were normalized to the perimeter of MN soma. Levels
of immunoreactivity for ionized calcium-binding adaptor mol-
ecule (Iba1), Mac-2, CD206, glial fibrillary acidic protein
(GFAP), 14-3-3, and S100β in the spinal cord and those of
CGRP and MMP-9 in MNs were quantified by analysing pixel
intensity following background subtraction. Spinal cord mi-
croglia morphology was quantified in confocal images from
Iba1-immunostained sections by using an ImageJ software
for skeleton analysis [AnalyzeSkeleton (2D/3D) from http://
imageJ.net/AnalyzeSkeleton]. Analysis was performed ac-
cording to a previously described procedure.40 For this, digital
photomicrographs were transformed to 8-bit grayscale and
then binarized to obtain a black and white image by means
of a formerly established threshold. Every image was manu-
ally edited to obtain an image with a continuous set of pixels
and gaps between processes belonging to neighbouring cells.
The image was then saved, and the plugin AnalyzeSkeleton
(2D/3D) was run. The accuracy of skeletonized images was
assessed, by creating an overlay of the obtained skeleton
with the corresponding original image.
The number and soma area of CGRP, IB4, and parvalbumin
(PV)-immunolabelled sensory neurons in the DRGs were mea-
sured on digital images.
The number and diameter of healthy and degenerating
myelinated axons were determined on ×60 images taken
from VR semithin cross sections stained with methylene blue.
The images were joined together to obtain a whole picture of
an entire nerve root transverse section; the diameter of the
myelinated axons was measured by delineating the outer
profile of the myelin sheath. Axon diameter and g-ratio mea-
surements were performed on electron micrographs of VRs.
ImageJ g-ratio plugin was used to obtain semiautomated
measurement of randomly selected nerve fibres; the axon di-
ameter was divided by the outer diameter of the myelin
sheath. At least 100 myelinated axons per mouse (4–5 mice
per condition) were measured.
Statistical analysis
Data are reported as mean ± standard error of the mean. The
statistical analysis was performed by either one-way or
two-way analysis of variance followed by post hoc
Bonferroni’s test or two-tailed Student’s t-test when only
two different groups were compared. The level of significance
was established at P ≤ 0.05. GraphPad Prism 6 software was
used for statistical analysis and graph presentations of data.
Results
Reduction in the locomotor activity of mice during
ageing
As expected, the body weight of animals was different with
age. A gradual increase in growth-related weight was ob-
served between 4 and 10months of age (Supporting Informa-
tion, Figure S1A). However, the older animals (19–28 months
of age) had significant lower average weight than the adults
(Supporting Information, Figure S1A). Moreover, as mice
age, a gradual and significant decline in locomotor activity
was detected with the open-field test, with this decline being
markedly prominent from 24 months onwards (Supporting
Information, Figure S1B and C). In our hands, rotarod and grip
strength tests were not suitable for monitoring the
age-associated progression of changes in motor skills; several
confounds and challenges in the interpretation of results
were found with these tests, particularly when performed
in young and adult mice: a number of them fell soon after
they were placed on either the rod or the wire grid, or re-
fused the tests. This aspect is not unusual in longitudinal as-
sessments or repetitive tests, as those performed in the
present study: after test repetitions, the animals end up
learning the innocuous consequences of falling.32 Although
these mice were excluded from the analysis, we think that
data from rotarod and grip strength tests were not reliable
enough to be conclusive. For this reason, we preferred to fo-
cus in results from open-field test.
Age-related electrophysiological changes
Data from the nerve conduction tests are detailed in Table 2.
Compared with adult mice, old (24months) animals exhibited
a reduction in conduction velocity, revealed by an increase in
the latency time, in both motor and sensory nerves.
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Moreover, a decline in the amplitude of the CMAP, which was
more evident in the distal PL muscle than in the more proximal
TAmuscle, was observed. The CMAP amplitude decline was at-
tributable to a slight decrease in both the number and size of
motor units (MUNE and single motor unit amplitude, respec-
tively). Interestingly, the sensory CNAP recorded in the toes
did not decrease significantly in old mice, suggesting that the
motor decline could be accounted, in part, to muscle loss
and compressive forces on the foot sole occurring with age.
With regard to the H wave, the electrical counterpart of
the spinal stretch reflex, the latency of the H wave in the PL
muscle was found to be longer in old mice than in adult mice,
although the mean amplitude was similar in both groups. The
H/M ratio, indicative of the excitability of the Ia afferent syn-
apses on spinal MNs, was higher in old than in adult mice,
likely due to compensatory mechanisms aimed to maintain
an adequate muscle reflex response.
Age-related changes in spinal cord motoneurons
On the basis of contradictory data on age-associated MN loss
previously reported in humans and rodents,9,14–17,21,22,41,42
we decided to re-examine this issue. We first analysed the
morphology of lumbar spinal cord MNs in cryostat sections
immunolabelled with an antibody against choline acetyltrans-
ferase, as an MN marker, and counterstained with fluores-
cent Nissl for neuron visualization (Figure 1A1–B2).
Compared with young MNs, adult MNs showed a slight (al-
though not significant) increase in soma size, consistent with
their higher degree of maturity and the increase in the axonal
length (Figure 1I). No significant reduction in the average
soma size was found in old MNs with respect to adult ones
(adult: 536.30 ± 33.03 μm2; old: 508.42 ± 47.22 μm2;
P > 0.05; Figure 1I), indicating that ageing does not entail
an atrophy of spinal cord MNs. We then counted the total
number of apparently healthy MNs present in the whole lum-
bar spinal cord on serial transverse paraffin sections stained
with H&E (Figure 1C–H). We found no significant changes in
the total number of lumbar MNs between young, adult, and
old mice (Figure 1J), indicating that no overt MN death oc-
curred during ageing. A detailed analysis of H&E-stained spi-
nal cord sections highlighted the presence of some MNs
having an abnormal basophilic dark appearance (Figure 1F
and H). These ‘dark’ MNs could be clearly distinguished from
commonly lighter stained (apparently healthy) MNs and per-
haps represent an injury-related change. Whereas dark MNs
were very scarce and found occasionally in young animals,
their presence increased with age, so in old animals, the pro-
portion of dark MNs was significantly higher than that in
young mice (Figure 1K). In some cases, dark MNs were
shrunken and displayed a deformed appearance, which
contrasted with other MNs that were hyperstained but main-
tain a normal architecture. MNs located in the ventral horn of
lumbar spinal cord are organized in three major columns
(anteromedial, intermediate, and anterolateral), which are
the reflection of muscular groups innervated by these MNs.
Thus, the anteromedial column MNs innervate axial muscles,
whereas MNs located in the intermediate and anterolateral
columns innervate proximal and distal hindlimb muscles, re-
spectively. By counting MNs in these three columns indepen-
dently, we observed that the number of apparently healthy
MNs slightly, but not significantly, decreased in the anterolat-
eral column of old mice with respect to adult animals (Figure
1L). We also noticed that the number of dark MNs rose with
age in the three MN columns, with this increase being more
pronounced in the intermediate column (Figure 1M).
It has been shown that in MN diseases, spinal MNs exhibit
differential vulnerability to degeneration.39,43,44 In this regard,
MNs innervating slow-twitch muscles (slow MNs) exhibit a
higher degree of resistance than those innervating
fast-twitch muscles (fast MNs). MMP-9 has been reported to
be selectively expressed in fast MNs and has been considered
as a determinant factor of specific vulnerable neuronal sub-
populations.45 We wanted to examine whether ageing in-
duced changes in the degree of MN vulnerability to
degeneration by analysing MMP-9 expression (a marker of
vulnerability) in the spinal cord of young, adult, and old ani-
mals. Compared with young mice, the proportion of lumbar
spinal cord MNs showing MMP-9-positive immunolabelling
was moderately reduced in adult animals (Figure 2A). This re-
duction was accompanied by a modest, although significant,
decrease in the intensity of MMP-9-immunostaining in adult
MNs (Figure 2B). No further changes in either the number of
MMP-9-positive MNs or MMP-9-staining intensity were no-
ticed in old mice compared with adult mice (Figure 2A and
B). In all the ages examined, MNs that were MMP-9 positive
displayed a larger size than those which were MMP-9 negative
(Figure 2C); this finding is in agreement with previous reports
and fits with the statement that MMP-9 is selectively
Table 2 Results from motor and sensory nerve conduction tests
Parameter Adult (6 months, n= 10)Old (24 months, n= 8)
TA Lat (ms) 1.48 ± 0.06 1.54 ± 0.08
TA CMAP (mV) 54.6 ± 1.9 50.7 ± 2.3
SMUA (μV) 1,572 ± 39 1,240 ± 109*
MUNE 42 ± 1.3 38 ± 1.7
PL Lat (ms) 1.89 ± 0.08 2.38 ± 0.17*
PL CMAP (mV) 7.51 ± 0.50 5.24 ± 0.68*
PL H wave Lat (ms)5.5 ± 0.3 6.7 ± 0.3*
PL H/M ratio (%) 17 ± 3.4 32 ± 4.1*
DgN Lat (ms) 1.27 ± 0.06 1.41 ± 0.05*
DgN CNAP (μV) 31.6 ± 2.8 29.5 ± 2.5
Weight (g) 29.1 ± 0.6 29.5 ± 0.7
CMAP, compound muscle action potential; CNAP, compound nerve
action potential; DgN, 4th digital nerve; Lat, latency at the peak of
the wave; MUNE, motor unit number estimation; PL, plantar
interosseous muscle; SMUA, single motor unit amplitude; TA,
tibialis anterior muscle.
Statistical comparisons are made with Student’s t-test and Sidak–
Bonferroni’s method for multiple comparisons.
*
P < 0.05 vs. adult group.
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expressed in fast, more larger sized, and vulnerable α-MNs.45
Moreover, our results suggest that once the degree of vulner-
ability is achieved in adulthood, no overt changes in MN sus-
ceptibility to degeneration occur with age progression.
In MNs, the neuropeptide CGRP is synthesized in the cell
body and subsequently transported to nerve terminals where
it appears to play a role in the development and maintenance
of muscle cells and NMJs.46–50 As previously reported by we
and others,49,51 CGRP was found in subpopulations of spinal
cord MNs and, in a particular MN pool, CGRP levels differed
between cells, so that some cells exhibited higher contents
of this neuropeptide than others. As expected from previous
studies (Matteoli et al.52 and our own observations), com-
pared with young mice, adult animals showed decreased
numbers of CGRP-immunostained MNs, with these exhibiting
lower levels of immunoreactivity (Figure 2D–F). No significant
changes in the number of MNs expressing CGRP were found
in old mice compared with adult animals; old MNs, however,
displayed a significant increase in CGRP content compared
with adult MNs (Figure 2E and F). Representative immuno-
staining for MMP-9 and CGRP in young, adult and old MNs
is shown in Figure 2G1–I4.
Ageing is accompanied by significant depletion of
afferent inputs to motoneurons
We analysed the density of afferent synapses on lumbar spi-
nal cord MNs of old mice compared with adult animals. The
number of synaptic boutons on MN somata was quantified
after immunostaining with anti-VAChT, VGluT1 and VGluT2,
and VGAT antibodies for cholinergic (C-boutons), glutamater-
gic excitatory, and GABAergic inhibitory synapses, respec-
tively (Figure 3C1–D2, G1–H2, K1–L2, and O1–P2). We
Figure 1 No significant motoneuron (MN) loss occurs in the lumbar spinal cord of mice with ageing. (A1–B2) Representative images of MNs in the spinal
cord of adult mice immunolabelled with an antibody anti-choline acetyltransferase (ChAT) (green), as an MN marker, and counterstained with fluores-
cent Nissl for neuron visualization (blue) as indicated. (C–H) Representative images of haematoxylin and eosin-stained MNs in the lumbar spinal cord of
(C and D) young, (E and F) adult, and (G and H) old mice. The appearance of these MNs is shown at a higher magnification in (D, F, and H); black arrows in
(F) and (H) indicate dark-stained and shrunken MNs; the red arrow in (H) points to a non-shrunken, hyperchromic, MN. (I) Average size (soma area in
μm2) and (J) number of apparently healthy MNs and (K) proportion of dark MNs (expressed as the percentage of MNs), in the lumbar spinal cord of
young, adult, and old mice. (L) Number of healthy and (M) dark MNs in anteromedial (AM), intermediate (IN), and anterolateral (AL) columns of ventral
horn. The data in graphs are shown as mean ± SEM, *P < 0.05 and **P < 0.01 (one-way or two-way ANOVA and Bonferroni’s post hoc test); 4–5mice per
age. Scale bars: (A2) = 100 μm [valid for (A1)]; (B2) = 10 μm [valid for (B1)]; (G) = 100 μm [valid for (C) and (E)]; (H) = 40 μm [valid for (D) and (F)].
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found that compared with adult MNs, old MNs exhibited a
significant decrease in the density of both C-boutons and glu-
tamatergic afferent terminals on cell bodies [~40% (VAChT),
45% (VGluT1), and 43% (VGluT2) decrease] (Figure 3A, B, E,
F, I, and J). No differences in the number of GABAergic synap-
ses were observed between old and adult MNs, although a
significant reduction (~20%) in the size of this type of inhibi-
tory afferents was noticed on MNs of old animals (Figure
Figure 2 Matrix metallopeptidase 9 (MMP-9) and calcitonin gene-related peptide (CGRP) immunoreactivity in lumbar spinal cord motoneurons (MNs)
of young, adult, and old mice; MMP-9 immunostaining is used as a marker of MN vulnerability. (A) Proportion of MNs displaying positive MMP-9-im-
munoreactivity (IR); the average intensity of the latter is shown in (B). (C) Size (in μm2) of MN somata exhibiting either positive or negative MMP-9
immunostaining. Age-related changes in the proportion of MNs showing (D) CGRP positivity and (E) in the immunoreaction (IR) intensity in these
MNs. (F) Percentage of MNs displaying both CGRP and MMP-9 immunostaining. (G1–I4) Representative images taken from spinal cord sections double
immunolabelled for MMP-9 (red) and CGRP (green) and counterstained with fluorescent Nissl staining (blue; for MN visualization). Data in the graphs
are expressed as the mean ± SEM, *P < 0.05, **P < 0.01, and ***P < 0.001 vs. adult (one-way ANOVA and Bonferroni post hoc test); n = 4–6 animals per
age; 50 MNs per animal were analysed. Scale bar: (I4) = 60 μm [valid for (G1–I3)].
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3M and N). These results indicate that ageing results in a
marked loss of central synapses, mainly involving cholinergic
and glutamatergic inputs to MNs.
Gliosis occurs in spinal cord during ageing
Activation of glial cells in the ventral horn of spinal cord has
been described to occur in different motoneuronal patholo-
gies including MN diseases and peripheral nerve injury.53–57
To explore whether glial activation also occurs in the aged
spinal cord, microglia and astroglia were analysed after
immunolabelling for Iba1 and GFAP, respectively (Figure
4A–F2). Compared with adult mice, old animals exhibited sig-
nificantly higher levels of both Iba1 and GFAP immunoreactiv-
ity [~93% and ~100% increase (P < 0.001 and P < 0.0001),
respectively] in the ventral horn of spinal cords (Figure 4A
and D), reflecting an increased density of microglial and
astroglial profiles. This indicates that prominent microgliosis
and astrogliosis occur around aged MNs. The degree of
ramification and complexity of microglia was quantified by
using a skeleton analysis procedure,40 which measures
Figure 3 Age-related changes in synaptic inputs to lumbar spinal cord motoneurons (MNs). (A–P2) Sections were immunostained to identify cholin-
ergic [vesicular acetylcholine transporter (VAChT)], glutamatergic [vesicular glutamate transporter 1 (VGluT1) and vesicular glutamate transporter 2
(VGluT2)], and GABAergic [vesicular GABA transporter (VGAT)] afferent synapses (green) and counterstained with fluorescent Nissl staining (blue)
to visualize MN cell bodies. Graphs show the average density [(A, E, I, and M) number of puncta per 100 μm soma perimeter and (B, F, J, and N) size
(in μm2)] of the different types of afferent terminals analysed. Representative confocal micrographs of (C1–D2) VAChT, (G1–H2) VGluT1, (K1–L2)
VGluT2, and (O1–P2) VGAT terminals contacting (C1–C2, G1–G2, K1–K2, and O1–O2) adult and (D1–D2, H1–H2, L1–L2, and P1–P2) old MNs are shown.
Data in the graphs are expressed as the mean ± SEM, *P < 0.05, **P < 0.01, and ****P < 0.0001 vs. adult (Student’s t-test); 50–60MNs were analysed per
animal (4–6 animals per age group). Scale bar in (P2) = 20 μm [valid for (C1–D2, G1–H2, K1–L2, and O1–P1)].
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different parameters of microglia morphology in an entire re-
gion of ventral horn (Figure 4G–L3). Compared with adult mi-
croglia, those of old mice displayed reduced lengths of
processes and increased number of endpoints in association
with significant greater amounts of branches, as indicated
by the increased numbers of triple and quadruple points
Figure 4 Ageing is accompanied by prominent microgliosis and astrogliosis in the spinal cord. (A–F2) Serial sections of lumbar spinal cord were immu-
nostained to visualize Iba1 and GFAP, for microglia and astroglia, respectively. Quantification of (A) ionized calcium-binding adaptor molecule 1 (Iba1)-
positive microglia and (D) glial fibrillary acidic protein (GFAP)-positive astroglia expressed as the percentage of the ventral horn area occupied by
Iba1-positive and GFAP-positive profiles. Representative confocal micrographs showing (B1–C2) Iba1 (red) and (E1–F2) GFAP (green) staining in the
ventral horn spinal cord of (B1–B2 and E1–E2) adult and (C1–C2 and F1–F2) old mice; fluorescent Nissl staining (blue) was used for motoneuron visu-
alization. (G–L3) Quantification of changes in microglial morphology by using a skeleton analysis procedure (see Materials and Methods section). The
average (G) branch length, (H) number of endpoints, and (I) of triple and (J) quadruple points are shown. Representative images showing (K1 and L1)
Iba1-stained profiles, (K2 and L2) the skeletonized images, and (K3 and L3) the overlay of the skeleton and the original image of microglia in (K1–K3)
adult and (L1–L3) old mice. Data in the graphs are expressed as the mean ± SEM; the spinal cord of four animals per age group was used for analysis; a
total of 40–45 sections (in A and D) and 7,000–12,000 cells (in G–J) per age were examined. *P < 0.05, ***P < 0.001, and ****P < 0.0001 vs. adult (Stu-
dent’s t-test). Scale bar: In (F2) = 30 μm [valid for (B1–C2) and (E1–F1)]; in (L1) = 20 μm [valid for (K1)].
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quantified (Figure 4G–J). These results indicated that with
ageing, gliosis involves structural changes in microglia, which
become more ramified and complex.
When activated, microglia and astroglia can attain one of
two opposing maturation phenotypes: M1 and M2 for mi-
croglia and A1 and A2 for astroglia.53,58 Whereas M1 and
A1 phenotypes have been related to inflammation and de-
generation, the M2 and A2 phenotypes have been associated
with anti-inflammatory and regenerative processes. To exam-
ine which type of microglial and astroglial phenotype is acti-
vated in the spinal cord as a consequence of age-related
reactive gliosis, Iba1 and GFAP immunocytochemistry was
combined with either Mac-2 or CD206 (for M1 or M2 microg-
lia) and 14-3-3 or S100β (for A1 or A2 astroglia)
immunolabelling, respectively59–62 (Figure 5A–T). Compared
with spinal cords of adult mice, those of old animals exhibited
a prominent increase in the density of harmful M1 (Mac-2-
positive) profiles and a modest reduction in M2 (CD206-pos-
itive) microglia (Figure 5A–D and I1–N). Similarly, the density
of A1 (14-3-3-immunostained) astroglia was found to be sig-
nificantly higher in spinal cords of old mice compared with
adult mice (Figure 5E, F, and O1–Q). Although S100β-
immunoreactivity (for A2 phenotype) only showed a moder-
ate, non-significant, decrease around old MNs, the propor-
tion of astroglia that stained positive for both GFAP and
S100β was significantly reduced in old mice compared with
adult animals (Figure 5G–H and R1–T). Overall, these findings
indicate that age-associated reactive gliosis implies an imbal-
ance in M1/M2 and A1/A2 phenotypes, leading to a polariza-
tion to harmful activated M1 and A1 states.
Early degenerative changes in motor nerves during
ageing
Ventral nerve roots, which are only formed by the most prox-
imal part of motor axons, were examined to assess their po-
tential structural alterations over the age process. We found
that compared with L4 VRs of adult animals, those of
middle-aged mice exhibited significantly higher numbers of
myelinated axons (Figure 6A). The average axonal diameter
(including the myelin sheath) of middle-aged VRs was signifi-
cantly greater than that of adult VRs (Figure 6B and C). In ad-
dition, there was a significant increase in the proportion of
degenerating axons in middle-aged VRs compared with adult
VRs (Figure 6D, H, and I). Middle-aged VRs had a high number
of axons whose myelin sheath structure exhibited focal dis-
ruption and, often, protruded into the axonal compartment
to ultimately form myelin spheroidal inclusions (Figure 6E,
H, and I); these inclusions, having the appearance of
myelin-like multilaminar balls, were only occasionally seen
in VRs from adult mice and had a similar morphology to that
observed during Wallerian degeneration.63 It was not unusual
to see myelin debris engulfed by macrophages in middle-aged
VRs. Interestingly, compared with adults, there was an in-
crease in the proportion of small myelinated axons in
middle-aged VRs, but this did not reach statistical significance
(Figure 6F). In middle-aged VRs, these small axons were usu-
ally seen clustered, contrasting with their homogeneous dis-
tribution in adult VRs (Figure 6G, H, and I). Clustered small
myelinated axons could represent newly formed, still imma-
ture, nerve branches, which originate by sprouting from
healthy motor axons. These results suggest that early in the
ageing process, some motor axons undergo degeneration,
and this is accompanied by the reactive generation of new
nerve fibres, in an attempt to replace those previously dam-
aged. G-ratio analysis allowed us to assess the relationship
between axon diameter and myelin thickness. Axon diameter,
by delineating the periphery of axon under the myelin
sheath, was found to be significantly longer in middle-aged
VRs than in those of adult VRs, suggesting that a certain de-
gree of motor axon swelling occurs during ageing (Figure
6J–N). In addition, the thickness of axon myelin was signifi-
cantly decreased in middle-aged VRs compared with adult
VRs, as indicated by the higher g-ratio average values found
in axons (g-ratios: adult age = 0.57 ± 0.12 and middle
age = 0.61 ± 0.01; n = 105–285 and 100–180 axons per ani-
mal, four and five animals, respectively, P < 0.05). As shown
in the scatter plot of Figure 6N, motor axons of
middle-aged mice that were larger corresponded to those
with higher g-ratios, indicating a thinner myelin sheath. The
ultrastructural appearance of middle-aged motor axons at
different stages of degeneration is shown in Figure 6O–Q.
Ageing is accompanied by alterations in dorsal root
ganglion sensory neurons
To ascertain whether ageing also affects to sensory neurons,
L4 DRGs of adult and old mice were examined. DRG sections
were processed for immunocytochemistry with antibodies
against CGRP and PV and also stained with IB4 lectin
(Supporting Information, Figure S2A–O2). These are specific
markers for different DRG neuronal subpopulations: CGRP is
present in peptidergic, small and medium-sized sensory noci-
ceptive neurons; IB4 stains nonpeptidergic, small-sized sen-
sory nociceptive neurons; and PV is present in large sensory
proprioceptive neurons innervating muscle spindles.64–66
Compared with the DRGs of adults, old DRGs showed a higher
proportion of CGRP-positive, IB4-positive, and PV-positive
neurons (Supporting Information, Figure S2A, F, and K). In
DRGs of old mice, all these neuronal populations exhibited a
significantly smaller soma size compared with those of adult
animals (Supporting Information, Figure S2B, C, G, H, L, and
M). These data suggest that ageing promotes significant
changes in the expression of CGRP, IB4, and PV in sensory
DRG neurons, which are accompanied by a marked atrophy
of both proprioceptive and nociceptive neurons.
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Figure 5 Age-related changes in the phenotype of spinal cord microglia and astroglia. (A–J) Serial sections of lumbar spinal cord of adult and old mice
were double immunostained for ionized calcium-binding adaptor molecule 1 (Iba1) and either (M1) Mac-2 or (M2) CD206 microglia, and glial fibrillary
acidic protein (GFAP) and either (A1) 14-3-3 or (A2) S100β astroglia. Quantification of (A and C) Mac-2-positive and CD206-positive profiles surrounding
motoneurons (MNs), based on the ventral horn area occupied by these immunostained profiles; the proportion of microglial profiles expressing both
Iba1 and either Mac-2 or CD206 is shown in (B) and (D), respectively. Quantification of (E and G) 14-3-3-positive and S100β-positive profiles surround-
ing MNs based on the ventral horn area occupied by these immunostained profiles; the proportion of astroglial profiles expressing both GFAP and ei-
ther 14-3-3 or S100β is shown in (F) and (H), respectively. Representative confocal micrographs used for data analysis showing (I1–K) Mac-2, (L1–N)
CD206, (O1–Q) 14-3-3, and (R1–T) S100β (all in green); microglial and astroglial markers were combined with Iba1 and GFAP, respectively (both in
red), and fluorescent Nissl staining (blue) for MN visualization. Higher magnification images of Iba1-positive microglial profiles also expressing either
(K) Mac-2 or (N) CD206 and GFAP-positive astroglial profiles also expressing either (Q) 14-3-3 or (T) S100β in the ventral horn of adult spinal cords
are shown. Data in the graphs are expressed as the mean ± SEM; the spinal cord of four animals per age group was used for analysis; a total of
40–45 sections per age were examined. ***P < 0.001 and ****P < 0.0001 vs. adult (Student’s t-test). Scale bars: In (S) = 50 μm [valid for (I1–J4), (L1–
M4), (O1–P4), and (R1–S4)] and in (T) = 10 μm [valid for (K, N, and Q)].
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Figure 6 Age-related changes in motor axons of mice. The analysis was performed in L4 ventral roots (VRs) of adult and middle-aged (middle) animals.
(A) Number and (B) diameter of VR myelinated axons. (C) Relative frequency of myelinated axon diameter (in μm); note in adult VRs the bimodal pro-
file indicative of axons originating from α-motoneurons (large axons) and γ-motoneurons (small axons). Proportion of axons showing a (D)
degenerating appearance, (E) some myelin inclusions, and (F) a small (≤6 μm) diameter; the number of small axon clusters (≥3 axons) in adult and
middle-aged VRs are shown in (G). Representative images of methylene blue-stained semithin cross sections of (H) adult and (I) middle-aged VRs used
for axon analysis; in (I), arrows indicate degenerating axons (red), a myelin inclusion inside an axon (green), and clusters of small axons (orange). Elec-
tron micrographs of (J) adult and (K) middle-aged VRs; note in (K) the distended appearance of some axons and the subtle changes in myelin structure
seen in middle-aged motor axons; arrow in (K) points out a degenerating axon. (L) Diameter (in μm) of motor axons, showing a significant increase in
axon size of middle-aged animals; the measurements were performed by delineating the axon periphery underneath the myelin sheath. Quantification
of myelin thickness by (M) g-ratio analysis and (N) scatter plot depicting (N) g-ratios in relation to axon diameter in VRs; all the measurements in (L–N)
were performed on electron micrographs taken from ultrathin cross sections of VRs at comparable levels. Representative electron micrographs of
middle-aged VRs showing in (O) a focal disorganization of myelin sheath resulting in two multilamellar myelin balls located inside a motor axon and
in (P) and (Q) motor axons in different stages of degeneration. Data in the graphs are expressed as the mean ± SEM, *P < 0.05 and **P < 0.01 vs. adult;
n = 4 adult and 5middle-aged VRs of different animals. Scale bars: In (I) = 25 μm [valid for (H)], (K) = 5 μm [valid for (J)], and (Q) = 5 μm [valid for (O and
P)].
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Structural and molecular changes in
neuromuscular junctions of hindlimb muscles
during ageing
The morphology and innervation of NMJs in TA, Sol, EDL, and
Gra muscles were examined following double immunostain-
ing for NF and synaptic vesicle protein 2 (for visualization of
presynaptic nerve terminals) combined with α-Bgtx (for iden-
tification of postsynaptic sites). In adult muscles, both presyn-
aptic and postsynaptic elements displayed a well-organized
appearance, with smooth and continuous nerve terminals en-
tering in endplates, the latter showing the ‘pretzel-like’ pat-
tern characteristic of mature, ‘healthy’ NMJs; postsynaptic
membranes exhibited numerous folds where α-Bgtx-labelled
AChRs were concentrated. In contrast, NMJs of old muscles
displayed structural alterations, which are consistent with
previous reports11,22,67–69: whereas some NMJs appeared
partially or fully denervated (Figure 7A and F1–H2), a high
proportion of innervated NMJs had overt signs of
polyinnervation (Figure 7B, I1, and I2); moreover, many nerve
terminals displayed a more complex branching and sprouting
(Figure 7E, J1, and J2). Motor endplates of old muscles were
also altered, showing increased size and fragmented appear-
ance (Figure 7C and D). Endplate denervation was frequently
associated with many small spots of clustered AChRs
scattered along the myofibers (Figure 7K–N). These spots
concomitantly displayed a faint positive signal for presynaptic
markers, indicative of a reactive neoformation of neuromus-
cular synaptic contacts (Figure 7O and P1–P4). We observed
some variations in these changes between muscle types stud-
ied: in old mice, the proportion of denervated NMJs was
much lower in TA muscles than other muscle types (Figure
7A); moreover, TA muscles showed more polyinnervated
NMJs than Sol and Gra muscles, with no obvious signs of
polyinnervation in EDL muscles of old mice (Figure 7D).
We and others have previously reported that during NMJ
development, motor nerve terminals initially contain high
levels of CGRP, which markedly decreases in mature NMJs;
nevertheless, CGRP is up-regulated in NMJs during conditions
of reinnervation and nerve sprouting.47,50,52,70 Consistent
with this, levels of CGRP in NMJs was very low in all adult
muscles examined compared with their young counterparts
(Figure 8C1–C3 and B1–B3). Conversely, a significant increase
in CGRP immunoreactivity was seen in NMJs of old muscles,
this augment being particularly prominent in the Gra muscle
(Figure 8A and F1–G3).
GAP-43 is a protein present in virtually all neurons during
axonal growth, being particularly abundant in axonal growth
cones (reviewed in Holahan71). It has been found that in
the neuromuscular system, GAP-43 is down-regulated in
MNs at the onset of synapse elimination in a process that is
regulated by muscle activity.72 Consequently, mature MNs
and their corresponding nerve terminals exhibit low levels
of GAP-43. In our study, adult muscles showed very low levels
of GAP-43 compared with their young counterparts (Figure
9B1–B3 and C1–C3). The levels of this protein, however, were
significantly increased in the NMJs of old muscles (Figure 9A
and D1–D3).
Agrin is a protein synthesized in the MN cell body and
axonally transported to the nerve terminal where once re-
leased concentrates at the synaptic basal lamina to play a cru-
cial role in the process of NMJ formation and maintenance.73–
76 We analysed then whether agrin content in NMJs was al-
tered in old muscles and found that NMJs of young and adult
muscles displayed low levels of agrin (Figure 9F1–F3 and G1–
G3). In comparison, NMJs of all muscles examined from old
mice, with the exception of Gra, exhibited a significant in-
crease in agrin expression (Figure 9E and H1–H3).
We next examined the expression levels of FGFBP1 and
TGF-β1 in muscles of adult and old mice. FGFBP1 is a secreted
protein that binds fibroblast growth factor proteins present at
the extracellular matrix enhancing its biological activity.77
FGFBP1 has been reported to be transcribed in muscle fibres,
where it appears to have a role in regenerating injured NMJs.78
On the other hand, TGF-β1 has been shown to regulate
FGFBP1 expression in cultured myotubes.79 We found that
all the examined muscles from young mice expressed both
FGFBP1 and TGF-β1. Although a diffuse and discrete immuno-
fluorescence was seen along the muscle fibres, both proteins
were mainly concentrated at the NMJs (not shown). However,
the expression levels of FGFBP1 and TGF-β1 changed with age.
Muscles of adult mice exhibited lower content of both pro-
teins compared with that of young animals. Moreover, com-
pared with adult muscles, old muscles displayed an increased
expression of FGFBP1 and TGF-β1, showing a pattern of immu-
noreactivity mostly restricted to the synaptic region of muscle
(Figure 10A, B, and C1–F3). Although both proteins were
mainly detected within the postsynaptic α-Bgtx-stained area,
some immunolabelling was also seen outside of this region,
suggesting that FGFBP1 and TGF-β1 are in part located in the
extracellular matrix around the NMJ.
Age-related changes in hindlimb skeletal muscles
Aged-related changes in skeletal muscles have been reported
in some murine models at histological and electrophysiologi-
cal levels68,80–84 (Hunter et al.85 and McKinnon et al.,86 as re-
views). We examined the degree of histopathological
alterations in different mouse muscles to assess the extent
by which muscular changes could account for the impaired
motor performance observed in old animals. Because muscle
denervation is typically associated with muscle atrophy, we
determined the wet weight, as an indicator of muscle mass,
and the cross-sectional area of muscles. Wet weights of adult
and old muscles did not exhibit significant differences, al-
though some reductions in the weight of Sol and EDL muscles
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Figure 7 Age-related changes in neuromuscular junctions (NMJs). Proportion of (A) denervated and of (B) monoinnervated and polyinnervated NMJs
in muscles of old mice. Changes in (C) NMJ size and (D) number of fragmented endplates in old muscles. All graphs show values as a percentage of
change compared with adult muscles; 50–100 NMJs per muscle from four adult and five old mice were analysed. (E) Percentage of NMJs exhibiting
terminal axonal sprouts in the muscles of adult and old mice; each point represents the percentage of sprouts found in 25–30 NMJs per muscle from
four adult and five old mice. Data in all graphs are expressed as the mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 vs. adult (one-
way ANOVA and post hoc Bonferroni’s test). Maximal projections of confocal stacks of NMJs from (F1 and F2) adult and (H1–J2) old muscles, as indi-
cated in panels. Muscle sections were stained with antibodies against neurofilament 68 KDa (NF) and synaptic vesicle protein 2 (SV2) (green) for pre-
synaptic nerve terminals and α-bungarotoxin (α-Bgtx) (red) for postsynaptic acetylcholine receptor (AChR). Microphotographs in (G1–J2) correspond to
representative old NMJs displaying different structural changes: (G1 and G2) partial innervation, (H1 and H2) denervation, (I1and I2, arrows)
polyinnervation, and (J1 and J2, arrow) terminal sprouting, most of these showing signs of endplate fragmentation; compare with the typical appear-
ance of an innervated adult NMJ in (F1 and F2). Representative images of α-Bgtx-stained (red) endplates in the (K and L) tibialis anterior (TA) and (M
and N) soleus (Sol) muscles from adult and old mice; arrows in (L and N) point to patches of AChRs scattered along the myofibers. (O) Density (number
per 1000 μm2) of extrasynaptic α-Bgtx-stained (AChR) spots in fibres of old muscles. (P1–P3) Representative images of the Sol muscle double
immunolabelled for VAChT (green) and NF (blue) and stained with α-Bgtx (red); arrows point to (P3) α-Bgtx-stained AChR spots that exhibit both
(P1) VAChT and (P2) NF positivity; the merged image for the three channels is shown in (P4). Scale bars: In (J2) = 20 μm [valid for (F1–J1)]; in
(N) = 20 μm [valid for (K–M)]; and in (P4) = 30 μm [valid for (P1–P3)]. EDL, extensor digitorum longus; Gra, gracilis.
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were seen in old animals compared with adults (muscle
weight reduction: ~23% Sol and ~43% EDL) (Figure 11A). No
significant differences were obtained when muscle weights
were normalized to body weight (muscle mass/body weight)
(Figure 11B). Gra muscles from old mice exhibited even
higher (although not significant) normalized weights com-
pared with those from adults. Additionally, compared with
adult muscles, old muscles did not exhibit significant changes
in cross-sectional areas (Figure 11C). We next analysed the
density of myofibers and found a reduction in the Sol and
EDL muscles of old animals, with the most prominent de-
crease observed in the EDL muscle (myofiber density reduc-
tion: ~24% Sol and ~37% EDL). This indicates that a
differential decline in the proportion of myofibers occurs in
distinct type of muscles with ageing. The effect of ageing on
myofiber size was analysed in muscle cross sections
immunolabelled for laminin and showed no significant differ-
ences in the average myofiber size between adult and old an-
imals for all the muscles examined (Figure 11E). Nevertheless,
compared with adult muscles, increased contents of connec-
tive tissue were found in all muscles from old animals, this in-
crease being more marked in the EDL (Figure 11F).
In agreement with previous reports,67 all the old hindlimb
muscles analysed exhibited high proportions of myofibers
showing centrally located nuclei (Figure 11G–O). In young
muscles, only a small percentage (0.5–1.5%, depending on
Figure 8 Ageing is accompanied by an increased expression of calcitonin gene-related peptide (CGRP) in neuromuscular junctions (NMJs) of hindlimb
muscles. (A) Changes in CGRP immunoreactivity (IR) in NMJs of old tibialis anterior (TA), soleus (Sol), extensor digitorum longus (EDL), and gracilis (Gra)
muscles expressed as the percentage of increase compared with respective adult muscles. (B1–D3) Representative confocal micrographs of
CGRP-immunostained (green) NMJs of Sol muscles from young, adult, and old mice; sections were also stained with α-bungarotoxin (α-Bgtx) (red)
for endplate identification. Data in the graphs are expressed as the mean ± SEM, ***P < 0.001 and ****P < 0.0001 vs. adult (one-way ANOVA and post
hoc Bonferroni’s test); one muscle for each muscle type taken from four adult and five old mice was used for analysis; 80–100 NMJs per muscle type
were examined. Scale bar in (D3) = 10 μm [valid for (B1–D2)].
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the muscle) of myofibers displayed central nuclei. These num-
bers significantly increased in old muscles, this increase being
more prominent in the TA and Gra muscles (~12% and 18%,
respectively) (Figure 11G). Because the presence of central
nuclei in a myofiber can be considered as an indicator of its
regeneration following degeneration,87,88 these results sug-
gest that over the ageing process, all limb muscles examined
undergo, to some extent, fibre degeneration and attempt to
regenerate these lost fibres.
Satellite cells (SCs) are muscle-resident stem cells required
for sustained muscle regeneration.89,90 SCs express paired
box protein 7 (Pax7), a transcription factor involved in the pro-
liferation of muscle precursor cells. To analyse age-related
changes in SCs, immunocytochemistry for Pax7 was combined
with DAPI staining in sections of adult and old mouse muscles.
Compared with adult muscles, decreased numbers of
Pax7-positive SCs were observed in all examined muscles from
old animals, although SC depletion only attained statistical sig-
nificance in Sol and EDL muscles (Figure 11P–S3).
From studies mainly performed in rats, it has been docu-
mented that ageing is associated with changes in the fibre type
profile of skeletal muscles. Thus, a transition from fast (type 2)
to slow (type 1) fibres, leading to a preponderance of the lat-
ter, appears to occur in aged muscles.91,92 We analysed the fi-
bre type (1, 2A, and 2B) composition of selected muscles by
using different isoform-specific anti-myosin heavy chain (I,
IIA, and IIB ) antibodies. As previously reported,68,93 in adult
mice, the Sol muscle was seen to be mainly composed of
slower fibres (types 1 and 2A), whereas EDL and TA muscles
showed a predominance of fast fibres (type 2B > 2A in EDL
and type 2A > 2B in TA); the Gra, which is the more proximal
hindlimb muscle, also consisted predominantly of types 2A
and 2B fibres (2A > 2B), with a lower proportion of type 1 fi-
bres. These myofiber type profiles exhibited differential
changes with ageing. Compared with adult muscles, all old dis-
tal hindlimb muscles analysed (TA, EDL, and Sol) displayed a
significant reduction in the proportion of type 2B fibres,
whereas the amount of type 2A fibres was found significantly
Figure 9 Age-related changes in growth associated protein 43 (GAP-43) and agrin expression in in neuromuscular junctions (NMJs) of hindlimb mus-
cles. Changes in (A) GAP-43-immunoreactivity (IR) and (E) agrin-IR (in arbitrary units [a.u.]) in NMJs of old tibialis anterior (TA), soleus (Sol), extensor
digitorum longus (EDL), and gracilis (Gra) muscles expressed as the percentage of increase compared with adult respective muscles. Representative
confocal images of NMJs of TA and Gra muscles from young, adult, and old mice immunostained for (B1–D3) GAP-43 and (F1–H3) agrin, both in green;
muscle sections were also stained with α-bungarotoxin (α-Bgtx) (red) for endplate identification. Data in the graphs are expressed as the mean ± SEM,
*P < 0.05; ***P < 0.001, and ****P < 0.0001 vs. adult muscles (one-way ANOVA and post hoc Bonferroni’s test); one muscle for each muscle type taken
from four adult and five old mice was used for analysis; 80–100 NMJs per muscle type were examined. Scale bars: In (D3) = 10 μm [valid for (B1–D2)]
and in (H3) = 10 μm [valid for (F1–H2)].
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decreased in the TA and EDL but dramatically increased in the
Sol. Additionally, all these old muscles showed a reduced pro-
portion of type 1myofibers with respect to adult muscles, but
only in the case of the EDL, this decline attained significance
(Figure 12A–M). Conversely, compared with adult mice, the
Gra muscle of old animals exhibited a prominent increase in
the proportion of types 1 and 2B fibres and a reduction in
the content of type 2A fibres (Figure 12A–M). These findings
contrast with those obtained in previous studies performed
in rat skeletal muscles, in which it has been reported that age-
ing results in a switch from type 2A to type 1 fibres in the slow
Sol muscle and from type 2B to type 2X (a type of fibre having a
resistance to fatigue intermediate between type 2A and type
2B fibres) in fast muscles.94,95
Lipofuscin, often called ‘age pigment’, consists of polymor-
phous and non-degradable autophagocytosed material that,
coming from different intracellular structures, accumulates
in lysosomes. The presence of lipofuscin in a cell is considered
the result from a oxidative stress process, in which oxidized
compounds, mainly of lipid and protein origin, are resistant
to hydrolysis by lysosomal enzymes.96,97 Lipofuscin has a
broad autofluorescence and, when excited by lights of di-
verse wavelengths in combination with proper barrier filters,
is easy to distinguish from immunolabelled fluorescent
structures.98 In our study, in comparison with muscles from
adult animals in which no lipofuscin aggregates were seen,
all the examined muscles from old mice exhibited prominent
lipofuscin accumulation (Figure 12N). This was especially
prominent in the Gra muscle, compared with the
slow-twitch Sol muscle showing the smallest amount of
lipofuscin aggregates. Within the muscle, the proportion of
lipofuscin granules varied considerably between myofibers,
and some of them appeared completely devoid of this pig-
ment (Figure 12O and P). Interestingly, in all muscles, the
largest fibres were those which exhibited the highest levels
of lipofuscin accumulation (Figure 12Q). The correlation be-
tween fibre type and accumulation of lipofuscin was explored
in the old TA muscle. We observed that type 1 fibres exhib-
ited a significantly lower content of the pigment compared
with types 2A and 2B fibres (Figure 12R).
Discussion
Despite the notable progresses made in the knowledge of the
etiological factors leading to ageing sarcopenia, the precise
causative mechanisms are far from fully understood. The in-
tricate interactions between the distinct types of cells and
Figure 10 Age-related changes in fibroblast growth factor binding protein 1 (FGFBP1) and transforming growth factor-β1 (TGF-β1) expression in neu-
romuscular junctions (NMJs) of hindlimb muscles. Quantification of changes in (A) FGFBP1-immunoreactivity (IR) and (B) TGF-β1-IR (in arbitrary units
[a.u.]) in NMJs of tibialis anterior (TA), soleus (Sol), extensor digitorum longus (EDL), and gracilis (Gra) muscles of old mice; changes are expressed as
the percentage of immunostaining increase compared with adult NMJs. Representative confocal micrographs of NMJs of Sol muscles from adult and
old mice immunostained for (C1–D3) FGFBP1 and (E1–F3) TGF-β1, both in green, as indicated; muscle sections were also stained with α-bungarotoxin
(α-Bgtx) (red) for endplate identification. Data in the graphs are expressed as the mean ± SEM, *P < 0.05, **P < 0.01, and ****P < 0.0001 vs. adult mus-
cles (one-way ANOVA and post hoc Bonferroni’s test); one muscle for each muscle type taken from four adult and five old mice was used for analysis;
80–100 NMJs per muscle type were examined. Scale bar in (F3) = 20 μm [valid for (C1–F2)].
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tissues shaping the neuromuscular system are complex and
hard to interpret in isolation. Indeed, results reported in the
literature are sometimes ambiguous, with strong divergences
in results obtained from different ageing models.99 Rodents,
mainly various rat and mouse strains, have been widely used
in studies of sarcopenia. Although it is unlikely that the ageing
processes in these animal models are entirely comparable with
those in humans, rodents provide an experimental paradigm
that allow us to overcome the obvious problems inherent to
human long lifespan, environmental and nutrition conditions,
and tissue sampling.99 However, most of the ageing research
performed in murine models has been restricted to specific
constituents of the neuromuscular system, providing a partial
view of cellular and molecular alterations leading to
sarcopenia. In an attempt to unify and clarify discrepant pub-
lished data, we conducted a detailed analysis of
ageing-related structural and functional alterations in the neu-
romuscular system of the C57BL/6JRj mouse, a
well-established model for sarcopenia. Here, all the main cellu-
lar components were simultaneously examined in each individ-
ual animal at specific time points. Additionally, changes in some
key molecules with well-established roles in the development
Figure 11 Effect of ageing on the histology of tibialis anterior (TA), soleus (Sol), extensor digitorum longus (EDL), and gracilis (Gra) muscles. (A) Wet
weight of muscles (in mg) and (B) weight of muscles relative to body weight (expressed in mg/g). (C) Changes in the total cross-sectional area of old
muscles (expressed as the percentage with respect to adult muscles). (D) Density of fibres in muscles (expressed as the number of myofibers in
1000 μm2 muscle cross-sectional area). (E) Average myofiber size (cross-sectional area in μm2) of the muscles. (F) Changes in the content of connective
tissue in old muscles (expressed as the percentage with respect to adult muscles). (G) Proportion of myofibers exhibiting central nuclei. (H–O) Repre-
sentative images of transversal muscle sections, double labelled with an antibody against laminin (lam) and 4′,6-diamidino-2-phenylindole
dihydrochloride (DAPI) for DNA. (P) Percentage of paired box protein 7 (Pax7)-immunostained cells (satellite cells) with respect to DAPI-positive nuclei
in adult and old muscles. Representative confocal images of Pax7 immunostaining (red) combined with immunolabelling for laminin (green) and DAPI
staining (blue) in (Q1–Q3) adult and (R1–R3 and S1–S3) old EDL muscle sections. A higher magnification view of Pax7 immunostaining in old EDL muscle
is shown in (S1–S3). Data in the graphs are expressed as the mean ± SEM, *P < 0.05, **P < 0.01, and ***P < 0.001 vs. adult; n = 5–6 muscles for muscle
type from different animals and age; number of fibres examined per muscle and mouse: (D and E) = 200, (G) = 3,000, and (P) = 100. Scale bar in
(O) = 50 μm [valid for (H–N)]; (R3) = 40 μm [valid for (Q1–R2)]; and (S3) = 10 μm [valid for (R1–R2)].
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and maintenance of neuromuscular innervation were also ex-
amined. A summary of themain results of this study is depicted
in Figure 13.
We reported that ageing is not accompanied by significant
MN death in the lumbar spinal cord of mice. Although the
presence of a certain degree of MN degeneration cannot be
excluded, our results suggest that MN loss should be consid-
ered as a minor event in the context of the neuromuscular
changes occurring during ageing. This finding is in contrast
with results from previous works in rodents9,15–17 and
humans,14,41 in which significant MN death has been re-
ported with ageing. Our results, however, are consistent with
data from studies that have shown the absence of MN
degeneration at advanced ages.21,22,100 The disparity in all
these results could be ascribed to differences in the animal
model species and age of animals included in the studies, seg-
ments of the spinal cord analysed, and the procedures uti-
lized for MN counting. Thus, most of the mentioned studies
have been performed in different rat strains and, in some
cases, without gender segregation. In the present analysis,
we only used male mice classified into three age groups, with
a strict age delimitation. Moreover, we counted the total
number of MNs in serial sections of the entire lumbar spinal
cord by using a standard and reliable procedure widely ap-
plied in the literature (see Clark and Oppenheim37 and also
Calderó et al.38,101), which allows an accurate estimation of
Figure 12 Age-related changes in fibre type composition and lipofuscin accumulation. (A) Changes in myofiber type composition in the old tibialis an-
terior (TA), soleus (Sol), extensor digitorum longus (EDL), and gracilis (Gra) muscles expressed as the proportion of types 1, 2A, and 2B fibres compared
with respective adult muscles (*P < 0.05 and **P < 0.01 vs. respective adult muscles; Student’s t-test). Representative images of (B–G) TA and (H–M)
Gra muscles from (B–D and H–J) adult and (E–G and K–M) old mice, showing myosin heavy chain I, IIA, and IIB immunostaining to demonstrate types 1,
2A, and 2B myofibers, as indicated. (N) Percentage of fibres containing lipofuscin granules in muscles from adult and old mice. (O) Percentage of old TA
muscle fibres with central or peripherally located nuclei containing lipofuscin aggregates. (P) Average size (cross-sectional area in μm2) of myofibers
with or without lipofuscin granules. (Q) Percentage of types 1, 2A, and 2B myofibers containing lipofuscin in the TA muscle of old mice. (R and S) Rep-
resentative fluorescent images of EDL and Gra muscle sections processed for laminin immunostaining (green); lipofuscin autofluorescence was excited
using 510–560 nm excitation and 590 nm emission filters; note that fibres with a small size are devoid of lipofuscin aggregates (arrows). Data in graphs
are shown as the mean ± SEM of fibres analysed from four adult and five old muscles of different animals (number of examined myofibers per muscle:
(N and O) = 400–700; (P and Q) = 300–500 (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; one-way or two-way ANOVA and post hoc
Bonferroni’s test). Scale bars: (M) = 50 μm [valid for (B–L)] and (S) = 100 μm [valid for (R)].
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Figure 13 Overview of age-associated changes in the mouse neuromuscular system. (A1–D1) The structural organization of the different components
of the system, including spinal cord motoneurons (MNs), neuromuscular junctions (NMJs), skeletal muscles, and dorsal root ganglion (DRG) sensory
neurons, is schematically represented. MNs, located in the ventral horn, project their axons throughout the ventral roots; motor nerve terminals es-
tablish synaptic contacts with skeletal muscle fibres (NMJs). (B1) In normal conditions, adult spinal MNs receive abundant synaptic inputs (synaptic
boutons), which can be identified by means of vesicular acetylcholine transporter (VAChT) (excitatory cholinergic), vesicular glutamate transporter 1
(VGluT1) and vesicular glutamate transporter 2 (VGluT2) (excitatory glutamatergic), and vesicular GABA transporter VGAT (inhibitory GABAergic)
markers. (A1) Glutamatergic (VGluT1-positive) afferents to MNs come from proprioceptive (parvalbumin-positive) sensory neurons located in the
DRG; cholinergic afferents (C-boutons) to MNs come from a small cluster of cholinergic interneurons (V0C), which are located near the central canal
of spinal cord. (B1) Spinal MNs are surrounded by abundant microglial and astroglial cells, which are in a resting state. The vast majority of MNs show a
‘healthy’, lightly haematoxylin and eosin-stained appearance; intermixed with them, some abnormally dark MNs can be occasionally seen in adult spi-
nal cords; these dark MNs could account for the presence of some degenerating motor axons that can be already observed in ventral roots of adult
mice. In adult muscles, both presynaptic and postsynaptic elements of NMJs exhibit a well-organized and ‘healthy’ appearance: smooth nerve termi-
nals enter in endplates displaying a ‘pretzel-like’ pattern; (C1) adult NMJs exhibited low levels of agrin, growth associated protein 43 (GAP-43), calci-
tonin gene-related peptide (CGRP), fibroblast growth factor binding protein 1 (FGFBP1), and transforming growth factor-β1 (TGFβ1). (D1) Diagram of
adult myofibers surrounded by connective tissue as can be seen in a transverse muscle section. (A2–D2) In the course of ageing, there is (i) an increase
in the number of dark MNs; (ii) a reactive gliosis in ventral horn with a raise in the proportion of harmful M1 microglia and A1 astroglia; (iii) a marked
loss of excitatory (cholinergic and glutamatergic) synaptic afferents and reduction in the size of GABAergic synaptic boutons on MNs; (iv) an increase in
the proportion of degenerated motor axons and the existence of signs of nerve sprouting and regeneration; and (A2 and B2) (v) an atrophy of sensory
proprioceptive and nociceptive DRG neurons and increased expression of their markers. (C2 ) Muscles of old mice exhibit signs of either
polyinnervation or denervation and fragmentation of endplates; these changes are accompanied by the increased expression of agrin, GAP-43, CGRP,
FGFBP1, and TGF-β1, suggesting and active process of NMJ remodelling and muscle reinnervation. Moreover, old muscles show numerous fibres with
lipofuscin accumulation and centrally positioned nuclei, indicative of muscle regeneration, and fibrotic tissue deposition between fibres; (D2) the pro-
portion of satellite cells were also markedly reduced in old muscles.
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neurons that die. This systematic approach is not often
employed in other studies. Although we did not find a signif-
icant reduction in the total number of MNs in old mice com-
pared with that in adult animals, we noticed a modest
decrease in the number of MNs located in the anterolateral
column, without changes in the anteromedial and intermedi-
ate columns. Because MNs from the anterolateral column in-
nervate distal hindlimb muscles, this finding is consistent with
the more prominent age-related involutive changes occurring
in these muscles.
Additionally, it is important to note the presence of MNs
with an altered histological appearance (dark MNs) scattered
across the lumbar spinal cord, particularly in the intermediate
column. Dark neurons have been described in healthy and
pathological brains of different animal models,102 but it re-
mains unclear whether they are the result from a pathological
change or merely represent an artefact. In this regard, an in-
appropriate tissue specimen fixation, particularly the time in-
tervals between collecting samples and fixation, appears to
provoke an increase in the proportion of dark cells in the ner-
vous tissue.103 Although we cannot completely exclude that
dark MNs are a consequence of tissue fixation defect, this
possibility appears unlikely because all our animals were in-
tracardially perfused and the spinal cords were rapidly re-
moved and subsequently postfixed. The fact that dark MNs
might reflect damaged cells is supported by the presence of
this type of neurons in the brain cortex and hippocampus fol-
lowing traumatic brain injury or focal cerebral ischemia.104,105
Nevertheless, the fate of dark neurons is not still clear. Al-
though it has been generally assumed that dark neurons are
‘sick’ cells prone to die and would be subsequently elimi-
nated, it is presently proposed that a number of them un-
dergo reactive mechanisms for cell death prevention.
Whether or not surviving neurons can conduct their appropri-
ate functions remains to be elucidated.102,104 In our analysis,
the proportion of dark MNs, although increased with age, did
not significantly change in old animals compared with adult
mice. Even considering that a certain number of dark MNs
undergo degeneration, only a minor proportion of them
would finally die. Indeed, we found that the number of
‘healthy’, lighter stained, MNs did not exhibit a significant de-
cline in the course of ageing. On the other hand, we noticed
no significant reduction in the proportion of MMP-9 MNs in
spinal cord of old animals, suggesting that vulnerable fast
MNs do not necessarily die during the ageing process.
The presence of dark, presumably sick, MNs in the spinal
cord of adult mice fits well with the pattern of changes we
observed in VRs. Previous work performed in young (2–
4 months) and old (22–25 months) mice has shown that in
the latter, VR motor axons displayed alterations in diameter
ratios and myelin, indicative of age-associated axonal degen-
eration82; in this study, however, no significant decline in the
number of motor axons has been found with ageing. Here,
we noticed that although in a low proportion, some motor
axons located in VRs of adult animals displayed signs of de-
generation and myelin inclusions. These alterations markedly
increased in VRs of middle-aged mice, in which numerous
myelin spheroidal inclusions and Wallerian-like degenerative
changes are often seen. Interestingly, middle-aged
(14 months) VRs exhibited increased numbers of clusters of
small myelinated axons, which likely are new nerve sprouts
originated from healthy axons. Overall these findings suggest
that sustained cycles of degeneration/regeneration and
sprouting from healthy axons occur, to greater or lesser de-
grees, throughout the lifespan. We assume that these
degeneration/regeneration cycles are exacerbated in older
mice, in an attempt to compensate for the loss of motor ter-
minal branches and synaptic sites in muscle.
Although MN death does not appear to be a relevant path-
ological process over the course of ageing, we cannot rule out
the possibility that MNs with a normal histological appear-
ance may have impaired function. In fact, we provide here
strong evidence that MNs of old animals suffer a prominent
loss of excitatory cholinergic and glutamatergic inputs, which
is in agreement with recent reports.100,106 Although we no-
ticed no age-associated changes in the density of inhibitory
GABAergic synapses, their size on old MNs was found signifi-
cantly reduced. MN deafferentation has also been widely re-
ported by us and others in murine models of MN diseases,
such as spinal muscular atrophy (SMA)107–111 and amyotro-
phic lateral sclerosis (ALS),109,112–115 and also following nerve
injury.116,117 Data from studies performed in these paradigms
support the idea that the loss of synaptic inputs is a process
that precedes MN degeneration and that a significant degree
of deafferentation is not necessarily associated to MN
death.107 This assumption is in agreement with the absence
of MN loss we found in the present work. It is reasonable
to assume that alterations in central synapses may negatively
impact on MN integrity and function. It is well known that
MN excitability is finely regulated by afferent synaptic inputs,
which mediate the generation of co-ordinated firing patterns
leading to muscle contractions.118 Because the accurate con-
trol of MN excitability is critical for a proper motor behaviour,
it is obvious that the latter can be markedly impaired by MN
deafferentation. Thus, overall, our results indicate that MN
dysfunction, rather than cell death, could explain the changes
in motor skills and in electromyography recordings seen in
our study.
An interesting finding in the present study is the prominent
microgliosis and astrogliosis found around aged MNs. This re-
sult indicates that ageing is accompanied by a
neuroinflammatory response in spinal cord ventral horn, as
it has been documented in different brain regions in healthy
elderly (reviewed in previous studies119–121). Ageing-related
chronic reactive gliosis has been associated to an increased
vulnerability of aged brain to neurodegenerative diseases. In-
deed, neuroinflammation has been reported to occur in a
number of neurodegenerative processes, including the MN
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disorders ALS and SMA.56,107,108,110,122–124 The role of neuro-
inflammation in chronic neurodegeneration, and particularly
in MN diseases, has still to be clarified. It is now accepted that
glial reaction in these pathologies may have either detrimen-
tal (cytotoxic) or beneficial (neuroprotective) effects on
MNs.124 In this regard, depending on the type of stressor trig-
gering the gliosis process, both microglia and astroglia can
achieve M1 and A1 (pro-inflammatory) or M2 and A2 (anti-in-
flammatory) reactive functional phenotypes, respec-
tively.53,58 Moreover, M1 and A1 reactive cells can turn into
M2 and A2 phenotypes, respectively, and vice versa, accord-
ing to the environment in which they are activated. In fact,
M1–A1 and M2–A2 phenotypes represent the extremes of a
continuum range of distinct reactive sates. The dynamic and
bidirectional transformation of M1/M2 and A1/A2 pheno-
types seems to play a critical role in neurodegeneration, in
which neuronal damage has been related to a sustained acti-
vation of M1 and A1 cells resulting in an imbalance between
the two microglial (M1/M2) and astroglial (A1/A2) subpopu-
lations. Additionally, activated M1 microglia can induce neu-
rotoxic A1 astrocytes, which have been found to be
abundant in diverse human neurodegenerative diseases,61 in-
dicating a cross-talk between microglia and astrocytes in neu-
roinflammation. We show here that gliosis in the aged spinal
cord is accompanied by a prominent increase in harmful M1
microglia and A1 astroglia, with a reduction in the proportion
of neuroprotective M2 and A2 phenotypes. A recent study
has reported that the depletion of microglia is able to prevent
or reverse the loss of muscle innervation in aged mice125; this
finding suggests an important pathogenic role of neurotoxic
microglia in the age-related neuromuscular decline, although
the mechanism by which microglia exert their detrimental ac-
tions in ageing is not known. It has been shown that both mi-
croglia and astrocytes are involved in synapse elimination
during neurodegeneration.126 A similar function has been as-
cribed to astrocytes in actively eliminating defective synap-
ses.127 The correlation between gliosis and MN
deafferentation, found here in the old spinal cord, suggests
a possible function of glial cells in the synapse elimination
during ageing, as it has also been reported for ALS and pe-
ripheral nerve injury.57,126 However, to our knowledge, no
published data exist on whether neuroinflammatory glial cells
actually eliminate synapses on diseased MNs. In a recent
study using a model of sciatic nerve axotomy, we found no
evidence of synaptic bouton enwrapping and phagocytosis
by microglia but noticed that microglial processes, recruited
by lesioned MNs, are in close contact with degenerating af-
ferent synaptic terminals, suggesting an active role of microg-
lia in the disintegration of adjacent presynaptic terminals on
MNs.57 It has been reported that activated microglia can pro-
duce molecules (i.e. nitric oxide, oxygen radicals, proteases,
and cytokines), which can induce neuronal damage and/or
the extracellular digestion of synaptic debris.128 A question
that needs to be answered is whether glial activation in aged
spinal cord is a primary event leading to the loss of normal
functional synaptic inputs to MNs with a subsequent neuro-
nal damage or, conversely, is a secondary response to an al-
tered synaptic function,129 as appears to occur in damaged
MNs after peripheral nerve transection.57
In this context, we found that ageing-related spinal cord
central synapse loss is accompanied by changes in DRG sen-
sory neurons. We noticed that with ageing, nociceptive
(CGRP-positive and IB4-positive) and proprioceptive (PV-pos-
itive) DRG neurons exhibited significant changes in their num-
bers and expression levels of their markers and atrophy of
cell soma. Sensory neurons showed increased expression of
CGRP and PV and higher staining with IB4. The increased pro-
portion of DRG PV-positive neurons differs from previous
data by Vaughan et al.130 showing no significant changes in
the numbers of DRG PV-positive neurons between
middle-aged (11- to 13-month-old) and old (15- to 21-
month-old) mice. Differences between both studies could
be related to mouse strains used because genetically modi-
fied mice were utilized in Vaughan’s work. In our study, how-
ever, neuron atrophy in old DRGs was particularly evident in
proprioceptive large, PV-positive neurons, which are the
source of the major synaptic inputs (Ia VGluT1 afferents) to
MNs. Ia afferents establish selective excitatory monosynaptic
connections with spinal MNs that, in turn, project their axons
to the same or related (homonymous or synergistic, respec-
tively) muscles from which they receive sensory feedback.131
This circuitry, which is essential for motor coordination and
posture, appeared to be impaired in old animals, as inferred
from progressive age-related alterations in mobility observed
in open field analysis. On the other hand, changes in the pro-
portion of DRG neurons expressing CGRP and in the levels of
this neuropeptide have been reported to occur in various in-
flammatory pain models.132–135 Therefore, the increased
numbers of DRG neurons expressing CGRP found in our study
are in concordance with the state of general, low-grade,
chronic inflammation that appears to be linked to elderly,
which has been considered an etiological factor of ageing
sarcopenia. In this regard, a systemic increase in
pro-inflammatory mediators coming from different sources
has been reported to occur in advanced ages.2
Nerve conduction studies allow the functional quantitative
assessment of large myelinated fibres. Thus, the amplitude of
the evoked action potentials is an index of the number of
conducting nerve fibres and the peripheral innervation,
whereas the nerve conduction velocity is related to axonal
calibre and myelination.136 The nerve conduction tests per-
formed indicate that the conduction of impulses is reduced
in advanced age, which is in agreement with previous reports
in laboratory animals137–139 and in humans.140–142 In this re-
gard, a previous longitudinal evaluation in mice has shown
that motor and sensory nerve conduction velocity increased
during young adult life, and then remained unchanged until
the last third of the lifespan, when it tended to decline.139
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Additionally, age-associated reduction in the amplitude of
motor and sensory nerve action potentials has also been re-
ported in animals138,139 and humans.140,141,143 Our present
results also indicate that the amplitude of CMAPs and CNAPs
tend to decrease with ageing, particularly in distal targets,
such as foot muscles and toe nerves. In fact, a slow loss of
myelinated fibres in peripheral nerves with ageing has been
demonstrated in several animal species.140,144–146 Indeed, in
a detailed morphometrical study in mice, we have found that
after 20 months of age, the sciatic nerve showed a noticeable
loss of both unmyelinated and myelinated axons, accompa-
nied by a decrease in axonal size and myelin thickness.146
The effect of sustained pressure on the paws over life has
been attributed as one of the determining factors for the par-
ticular functional loss of plantar muscles compared with more
proximal and tail muscles,145 as we have observed here in old
mice.
MUNE analysis reflects well the potential loss of MNs with
ageing.147 The reduction in MUNE found here in old mouse
muscles was only mild and is in agreement with the absence
of significant MN degeneration. Following loss of an MN, mo-
tor axons are able to sprout collateral branches within the
own muscle and thus increase the size of the corresponding
motor unit,148 allowing an efficient compensatory mechanism
for maintaining muscle force. However, with advanced age-
ing, the capability for collateral sprouting149 and maintenance
of size after expansion of the motor unit150 is defective. In ad-
dition, alterations of NMJ function as a consequence of alter-
ations in fast-twitch, fast-fatigable motor units have been
described in aged rodents,151 which cause a decrease in the
mean size of remaining motor units, as we found here.
Whether NMJs are stable over the lifespan and if they
change their morphology with ageing are debatable. Some
early studies in rabbits and cats have shown that a certain de-
gree of nerve sprouting and a continuous turnover of NMJs
occur in normal muscles.152 However, more recent data in
mice and humans support the idea that NMJs are generally
stable for most of the lifespan.28,153 In agreement with previ-
ous published reports,67–69,82,154 we found, in old muscles, a
significant amount of NMJs exhibiting conspicuous plastic
changes, including partial or complete denervation,
polyinnervation, increased nerve terminal branching com-
plexity, and sprouting. Moreover, overt signs of endplate
fragmentation and ectopically innervated AChR clusters
throughout the myofiber were seen in old muscles. Overall,
these observations fit with the hypothesis that ageing entails
a continuous process of muscle denervation/reinnervation
(reviewed in Larsson et al.6). In this regard, we noticed that
aged muscles displayed a significant increase in some mole-
cules having specific roles in development, maturation, plas-
ticity, and stability of NMJs. These molecules include CGRP,
GAP-43, agrin, FGFBP1, and TGF-β1. CGRP, GAP-43, and agrin
are developmentally regulated proteins, which are
synthetized in MN cell bodies and axonally transported to
nerve terminals, where they are released and exert their
function. Whereas GAP-43 is highly expressed in the growth
cones of motor axons and are involved in developmental ax-
onal outgrowth,71 agrin plays a crucial role in the initiation of
NMJ formation by clustering AChRs and, also, in the preserva-
tion and regeneration of the adult NMJ.74,75 On the other
hand, in the neuromuscular system, CGRP has been proposed
to act as a communication molecule between MNs and skel-
etal muscles and is involved in the development and mainte-
nance of NMJs and muscle cells155,156; motoneuronal CGRP is
up-regulated following nerve injury, but its raised levels de-
cline with the morphological and functional recovery of mo-
tor innervation, suggesting a function of the neuropeptide
in axonal growth and NMJ plasticity.49,50,157,158 On the whole,
these three molecules were found in low levels in muscles of
adult mice compared with young animals but were clearly
up-regulated in motor nerve terminals of old muscles. This
finding suggests an active role for these proteins in the regu-
lation of the compensatory nerve terminal sprouting and re-
innervation of denervated muscles in ageing.
The FGFBP1 has been found to be up-regulated in skeletal
muscles of a mouse model for SMA.159 More recently, it has
been described that NMJs of normal adult muscles express
and concentrate FGFBP1, but its levels decrease when NMJs
undergo pathophysiological changes as occurred in the
SOD1G93A mouse model for ALS.79 Compared with the rela-
tive high intensity of immunostaining for FGFBP1 observed
in NMJs of young muscles (not shown), we found that
FGFBP1-immunolabelling markedly declined in adult NMJs
but increased again in old NMJs, particularly in those of the
Gra muscle. The increased content of FGFBP1 in old muscles
is in concordance with its proposed function in promoting
NMJ repair78 and suggests a role of this protein in the process
of age-related NMJ remodelling and muscle reinnervation.
The elevated levels of FGFBP1 noticed by immunocytochem-
istry in old muscles contrast with the findings by Valdez’s
group,79 which have reported a significant reduction in
FGFBP1 transcripts in the TA muscle of 24-month-old mice.
This divergence could be explained by the differences in
methodology and animals used in this latter study,79 in which
the FGFBP1 expression levels have been examined by quanti-
tative PCR in aged wild-type heterozygous (FCFBP1+/) ani-
mals of homozygous (FCFBP1/) FGFBP1 knockouts.
Nevertheless, in agreement with data from this same study,
we found higher contents of TGF-β1 in muscles of young
and old animals than in those of adult mice. Our findings
showing increased levels of both TGF-β1 and FGFBP1 in old
muscles in vivo are difficult to reconcile with the suggested
role of TGF-β1 in inhibiting FGFBP1 expression found in cul-
tured myotubes.79 However, the increased levels of TGF-β1
could explain some changes found in muscles of old mice. Al-
terations in the expression of TGF-β1 and its signalling path-
ways have been associated with inherited and acquired
myopathies (reviewed in Burks and Cohn160). In this regard,
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an increase in circulating TGF-β1 levels has been found to be
associated with sarcopenia. TGF-β1 is considered a potent
regulator of tissue wound healing and fibrosis in the skeletal
muscle161 and appears to play an important role in promoting
the transformation of myoblasts in myofibroblastic cells.
Myofibroblasts have been involved in tissue fibrosis and
could be responsible for the increased proportions of connec-
tive tissue we found in old muscles. It has been proposed that
elevated systemic or local levels of TGF-β1 and skeletal mus-
cle fibrosis could interfere with the activation and prolifera-
tion of SCs with the subsequent impairment of myofiber
regeneration and muscle remodelling in sarcopenia.160,162 In
this regard, it should be expected that the reduction in the
proportion of SCs we found in old muscles negatively affects
the regenerative capacity of muscles and exacerbates muscle
fibrosis.163,164 Connective tissue deposition was found in all
muscles from old mice, although it was particularly conspicu-
ous in the EDL and Sol. Although the fibrotic tissue deposition
would contribute to worsen the impaired muscle function in
ageing, fibrosis could explain the absence of significant
age-related changes in the muscle weight we observed in
EDL and Sol muscles despite myofiber loss.
Interestingly, compared with adult mice, no statistically
significant differences in muscle mass were found in old mus-
cles, although in the latter, some decrease in the average
weight was observed in Sol and EDL muscles. Overall, these
findings suggest that ageing has only a minor impact on mus-
cle mass of mice, a result which contrasts with reported data
from human studies but is in agreement with previous analy-
sis conducted in ageing rats and mice: in these models, only
moderate or very small decreases in muscle mass have been
observed compared with humans (reviewed by Ballak
et al.99). Moreover, the fact that Sol and EDL muscles, two
distal hindlimb muscles with different fibre type composition,
have a greater tendency for age-related mass reduction than
the distal TA or the proximal Gra muscles corroborates the
hypothesis that different muscles are impacted by varying de-
grees over the ageing process. This may suggest that muscle
wasting in advanced ages could be more linked to both mus-
cle location and specific function than to fibre type composi-
tion. In fact, others have reported differences in age-related
muscle mass loss between mouse hindlimb (Sol and EDL)
and the cervical (sternomastoid and cleidomastoid) muscles,
with no changes in the latter.165 In addition, it has been
shown in rats166 and also in humans167 that hindlimb (leg)
muscles are more severely affected than forelimb (arm) mus-
cles. Our results indicate that even muscles in proximity of
each other, such as TA and EDL, also display differential
age-related histological alterations, with a significant de-
crease in fibre density in the EDL muscle and no overt
changes in the TA muscle of old animals. These observations
are somehow surprising because EDL and TA muscles have a
similar fibre type composition and belong to the same func-
tional group, and, consequently, we should expect
comparable age-associated alterations in both muscles. These
observations point to the fact that the specific function and
the degree of activity of muscles could be main determinants
of muscle wasting severity in elderly.
All the old muscles examined in our study displayed fibres
having central nuclei, with much higher proportions of them
in TA and Gra muscles. The existence of increased amounts
of fibres with centrally located nuclei has been associated to
different muscle disorders and repair.88 In the case of muscle
repair, the fusion of activated SCs with the damaged myofiber
causes the incorporation of new nuclei, whichmove first to the
centre of the myofiber before moving out to its periphery.
Therefore, the presence of centrally positioned nuclei has
been considered as an indicator of myofiber regeneration. In
this regard, the finding of elevated numbers of fibres with cen-
tral nuclei in old muscles might reflect a process of continual
myofiber regeneration in response to a persistent muscular
impairment occurring with ageing. Changes in the NMJs lead-
ing to denervation/reinnervation could be one of the main
drivers of fibre degeneration/regeneration cycles in agedmus-
cles. However, an intrinsic alteration in myofibers as a cause of
muscle dysfunction in elderly cannot be excluded. Thus, nu-
clear misposition should be considered not only a sign of mus-
cle pathology but also a cause of it.88 In any case, the finding of
myofibers with centrally positioned nuclei in all the old mus-
cles, but at different proportions, suggests that myofiber re-
generation in ageing is a general feature shared by distinct
types of hindlimb muscles, although they exhibited a highly
variable degree of repair. Interestingly, muscles with the low-
est numbers of myofibers with central nuclei (EDL and Sol) also
appeared to display the lowest capacity of myofiber regenera-
tion: both these muscles from old animals, predominantly the
EDL, exhibited a reduction in the density of myofibers, indicat-
ing that regeneration cannot fully counteract myofiber loss. In
fact, we failed to detect any decline in the fibre density in the
old TA and Gra muscles, which have the highest number of fi-
bres displaying central nuclei.
Studies performed in rat models have reported that
age-related changes in muscle innervation results in a de-
creased proportion of type 2 myofibers, and particularly of
those having a glycolytic metabolism (type 2B)94,95 (see also
McKinnon et al. and Schiaffino and Reggiani86,92 as reviews).
Type 2 myofibers are innervated by fast, MMP-9-positive, vul-
nerable MNs.43,45 The age-related decrease in the proportion
of type 2 myofibers appears to be compensated by the in-
creased numbers of type 1 myofibers,94,95 which, innervated
by slow MNs, have an oxidative metabolism and are more re-
sistant to degeneration. In fact, several analyses conducted in
models of MN diseases have reported that MNs and synapses
innervating type 2B myofibers degenerate earlier than those
innervating types 2A and 1myofibers.168,169 These results have
been correlated with differences in the degree of plasticity of
synapses: synapses exhibiting a low sprouting competence
are the most vulnerable, whereas those which react with a
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robust sprouting are selectively resistant.168 Thus, it has been
proposed that fibre type 2 to 1 transition in ageing is the con-
sequence of a preferential loss of fast, vulnerable, MNs with
the resulting denervation of 2B fibres and their subsequent in-
nervation by slow, resistant, MNs with high sprouting capacity.
In fact, myofiber type 2 to type 1 switching has been reported
to occur in models of MN diseases, such as SMAmice.39,170 Be-
cause skeletal muscles with a higher content of type 1 fibres
are more resistant to wasting than those with a predominance
of type 2 fibres,92,171 it has been proposed that fibre type 2 to
type 1 transition in these diseases could result from the activa-
tion of metabolic oxidative myogenic compensatory pro-
gramme aimed at limiting muscle dysfunction. Our results
indicate that a similar mechanism does not likely operate in
muscles of C57BL/6J mice with ageing. In divergence with data
from ageing rat studies, with the exception of Gra muscle, we
did not observe any significant augment in the proportion of fi-
bre type 1 in old muscles. Conversely, a trend to an age-related
decrease in the amount of type 1 fibres was seen in all the dis-
tal hindlimb muscles, this reduction being particularly promi-
nent in the EDL muscle. Additionally, in the old slow-twitch
Sol muscle, the proportion of type 2A fibres was found promi-
nently increased at the expense of a reduction in the number
of types 1 and 2B fibres. These results corroborate previous
findings indicating that fibre type 2 to 1 switching in ageing is
not a common feature shared by all muscles, with profound
differences existing between fast-twitch and slow-twitch mus-
cles.165 Additionally, our data suggest that differences in
aged-related myofiber type transition also occur between
muscles having similar fibre type composition but different
limb topography (i.e. the distal TA or EDL and the proximal
Gra muscle; all of them are fast-twitchmuscles). It is important
to note that there is a substantial inconsistency between the
age-related changes in fibre type composition reported in the
literature. Some studies in human muscles have found a type
2 to type 1 fibre switching with a reduction in the former,
whereas other analyses have conversely reported
aged-related increases in type 2 fibres; other works, however,
have found no changes in muscle-fibre type profiles in humans
with ageing.172–175 Similar disparities in age-associated fibre
type transitions have been found in rodent studies.165,176–178
The absence of a consistent pattern of fibre type alterations,
we found in old muscles, correlates with the absence of sub-
stantial MN death and, more specifically, with the lack of a de-
cline in the proportion of vulnerable (MMP-9-positive) MNs.
Overall, our data suggest that fibre type changes are more of
a consequence of MN dysfunction than cell death.
The accumulation of lipofuscin in postmitotic cells is widely
considered a hallmark of ageing (reviewed by Brunk and
Terman96 and Gray and Woulfe97). In this respect, the pres-
ence of lipofuscin granules in brain cells, particularly in cere-
bral cortex and motor areas, is one of the most consistent
features of ageing.179 In a recent study, the content of
lipofuscin aggregates has been analysed in MNs of old mice
and rhesus monkeys as a marker of neuronal ageing.100 In
this work, authors have shown a variable degree of lipofuscin
accumulation among MNs, suggesting that not all MNs aged
either at a comparable rate or at the same time. In a similar
way, we noticed that in sharp contrast with the absence of
lipofuscin in adult muscles, all old muscles from C57BL/6JRj
mice accumulate this pigment in the myofiber cytosol. We
observed, however, remarkable variations in the amounts of
lipofuscin between the different muscles examined, with
the slow-twitch Sol muscle exhibiting the lowest proportion
of the lipid pigment and the fast-twitch Gra muscle the
highest. These differences correlate with the finding that
the fast-twitch types 2A and 2B myofibers are those which
exhibited the highest content of lipofuscin in old muscles,
with type 1 fibres almost devoid of the pigment granules. This
indicates that vulnerable (types 2A and 2B) fibres are more
prone to ageing than type 1 fibres. Large numbers of
lipofuscin granules have been reported to be present in dif-
ferent muscular dystrophies in humans and young
dystrophin-deficient mdx mice.180–182 It has been proposed
that cellular lipofuscin accumulation is the consequence of
an oxidative stress process making cellular components
undegradable by lysosomal enzymes.96 Indeed, the treatment
of young mdx mice with antioxidants reduces lipofuscin accu-
mulation and improves muscle function. Oxidation, as a cause
of lipofuscin formation, seems to be also linked to a de-
creased degradative capacity of lysosomes, which would oc-
cur with age or under pathological conditions. It is not
clear, however, whether lipofuscin really interferes with nor-
mal cellular function or, conversely, the accumulation of this
pigment is a mere result from a previous cellular disturbance.
Several pieces of evidence suggest that a detrimental feed-
back loop leading to lysosomal and ubiquitin/proteasome
pathway inhibition may occur as a result of lipofuscin aggre-
gation. In any case, it seems plausible that the accumulated
lipofuscin makes cells more vulnerable to pathologic stimuli
and decreases the cellular adaptability and response capacity
to injury.96 In the case of aged MNs, lipofuscin accumulation
does not associate with cell atrophy or death, although it ap-
pears to correlate with the unequivocal alterations occurring
with ageing in motor nerve terminals.100 Moreover, although
the lipofuscin aggregation is significantly higher in muscle fi-
bres with peripheral nuclei, the presence of a certain propor-
tion of fibres with central nuclei indicates the existence a
newly regenerated myofibers already containing the age pig-
ment. Whether or not lipofuscin granules in these fibres cor-
relates with an impaired cellular function already present in
the initial steps of myogenic programme should be analysed.
In summary, ageing in mice is accompanied by defects in
motor skills and changes in the electromyographic patterns.
These alterations occur in the absence of significant MN
death but are associated to prominent MN deafferentation
and reactive gliosis, which possibly contributes to MN impair-
ment. Therefore, age-related MN dysfunction rather than
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death could be responsible of structural and molecular alter-
ations in motor axons, MNJs, and skeletal muscles found in
senescence. The ageing progress appears to entail continuous
cycles of motor axon degeneration/regeneration and
sprouting, as deduced by the signs of morphologically altered
motor axons in adult mice and the increased numbers of clus-
tered small myelinated axons found in VRs of middle-aged
mice. Although the distinct types of old muscles examined
share some common features indicative of the ageing pro-
cess, the profile of some alterations is markedly variable be-
tween muscles. This variability exists even between muscles
located in close vicinity and having similar fibre type compo-
sition, suggesting that the degree of activity and specific func-
tion of muscles, rather than their topography and fibre
typology, has greater impact on age-related muscular
changes. Further research is needed to draw more reliable
conclusions concerning the pathogenic mechanisms underly-
ing neuromuscular alterations during ageing and the extent
of their contribution to development of sarcopenia.
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Figure S1. Aging is accompanied by a decline in body weight
and motor performance measured with the open-field test.
A) Body weight in adult (4–10 months) and old (19–
28 months) mice; ***p < 0.001 vs. adult 46 weeks. B and C)
Motor performance assessed by open-field test in mice from
24 months of age on; the distance (in cm, B) and average
speed (cm/s, C) in the course of the 16 week-period in which
measurements were performed. *p < 0.05, **p < 0.01, and
***p < 0.001 vs. 0 weeks. Data in the graphs are shown as
the mean ± SEM, n = 15 (84 to 112 weeks); n = 8 (~116 weeks
onwards).
Figure S2. Age-related changes in DRG sensory neurons. A-C,
F-H and K-M) Proportion (A, F, K) and soma area (B, G, L) of
sensory neurons expressing CGRP (A, B), IB4 (F, G) and PV (K,
L) in DRGs. C, H, M) Relative size-frequency (expressed as
soma area in μm2) histogram of DRG neurons showing CGRP-
(C), IB4- (H) and PV- (M) positive staining. D1-O2) Representa-
tive micrographs taken from DRG cryostat sections processed
for CGRP, IB4 and PV staining (green), as indicated. Sections
were also counterstained with fluorescent Nissl (red) for neu-
ron visualization. Data in the graphs are expressed as the
mean ± SEM, **p < 0.01 and ***p < 0.001 vs. adult; n = 4 ven-
tral roots of different animals per age group (Student’s t-
test). Scale bar: in O2 = 100 μm2 (valid for D1-E2, I1-J2 and
N1-O1).
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